Document:

Exhibit 10.5

 

COMPANY SHAREHOLDER VOTING AGREEMENT

  

This
COMPANY SHAREHOLDER VOTING AGREEMENT (this “Agreement”) is made and entered into as of September 16, 2021, Gogoro
Inc., an exempted company incorporated with limited liability under the Laws of Cayman Islands (the “Company”), Poema
Global Holdings Corp., an exempted company incorporated with limited liability under the Laws of Cayman Islands (“SPAC”),
and the persons listed on Schedule A hereto (each, a “Company Shareholder” and collectively, the “Company
Shareholders”).

 

WHEREAS,
capitalized terms used but not otherwise defined in this Agreement shall have the meanings ascribed thereto in the Agreement and Plan
of Merger (the “Merger Agreement”) entered into by and among the Company, Starship Merger Sub I Limited, an exempted
company incorporated with limited liability under the Laws of Cayman Islands and a wholly-owned subsidiary of the Company (“Merger
Sub”), Starship Merger Sub II Limited, an exempted company incorporated with limited liability under the Laws of Cayman Islands
and a wholly-owned subsidiary of the Company (“Merger Sub II”), and SPAC, pursuant to which, among other things, (i) Merger
Sub will merge with and into SPAC, with SPAC surviving the First Merger as a wholly owned subsidiary of the Company (the “First
Merger”), and (ii) SPAC will merge with and into Merger Sub II, with Merger Sub II surviving the Second Merger as a wholly
owned subsidiary of the Company (the “Second Merger” and together with the First Merger, the “Mergers”).

 

WHEREAS,
each Company Shareholder is, as of the date of this Agreement, the beneficial and sole legal owner of the number of Pre-Subdivision Shares
or Company Series C Preferred Shares (as applicable), set forth opposite such Company Shareholder’s name on Schedule A
hereto (such Company Series C Preferred Shares and Pre-Subdivision Shares, together with any other Pre-Subdivision Shares acquired
by such Company Shareholder after the date of this Agreement and during the term of this Agreement, including those subscribed by such
Company Shareholder immediately upon the Company’s repurchase of the Company Series C Preferred Shares held by such Company
Shareholder, being collectively referred to herein as the “Subject Shares”).

 

WHEREAS,
as a condition to their willingness to enter into the Merger Agreement, the Company and SPAC have requested that each of the Company
Shareholders enter into this Agreement.

 

NOW,
THEREFORE, in consideration of the premises set forth above, which are incorporated into this Agreement as if fully set forth
below, and intending to be legally bound hereby, the parties hereto agree as follows:

 

    1 

     

    

 

Article I

Representations and Warranties of the Company Shareholders

 

Each Company Shareholder severally and not jointly
hereby represents and warrants to the Company and SPAC during the period starting from the date hereof until the earlier of (1) the
Closing and (2) the termination of the Merger Agreement in accordance with its terms (the “Exclusivity Period”)
as follows:

 

1.1            Corporate
Organization. Such Company Shareholder has been duly organized, is validly existing and is in good standing under the Laws of its
jurisdiction of organization and has the requisite corporate power and authority to own, lease or operate its assets and properties and
to conduct its business as it is now being conducted. Such Company Shareholder if not an individual is duly licensed or qualified and
in good standing (where such concept is applicable) as a foreign entity in each jurisdiction in which the ownership of its property or
the character of its activities is such as to require it to be so licensed or qualified, except where failure to be so licensed or qualified
would not, individually or in the aggregate, reasonably be expected to prevent or materially delay or materially impair the ability of
such Company Shareholder to consummate the transactions contemplated hereby. If such Company Shareholder is an individual, such Company
Shareholder has full legal capacity, right and authority to execute and deliver this Agreement and to perform his or her obligations
hereunder.

  

1.2            Due
Authorization. Such Company
Shareholder has all requisite corporate power and authority to execute and deliver this Agreement, to perform its obligations hereunder
and thereunder and to consummate the transactions contemplated hereby. The execution, delivery and performance of this Agreement and
the consummation of the transactions contemplated hereby have been duly and validly authorized and no other corporate or equivalent proceeding
on the part of such Company Shareholder is necessary to authorize this Agreement or such Company Shareholder’s performance hereunder.
This Agreement has been duly and validly executed and delivered by such Company Shareholder and, assuming due authorization and execution
by each other party hereto, this Agreement constitutes a legal, valid and binding obligation of such Company Shareholder, enforceable
against such Company Shareholder in accordance with its terms, subject to the Enforceability Exceptions. If this Agreement is being executed
in a representative or fiduciary capacity, the person signing this Agreement has full power and authority to enter into this Agreement
on behalf of such Company Shareholder.

 

1.3            Governmental
Authorities; Consents. Assuming the truth and completeness of the representations and warranties of other parties hereto contained
in this Agreement, no consent of or with any Governmental Authority on the part of such Company Shareholder is required to be obtained
or made in connection with the execution, delivery or performance by such Company Shareholder of this Agreement or the consummation by
such Company Shareholder of the transactions contemplated hereby, other than (a) applicable requirements, if any, of the Securities
Act, the Exchange Act, and/ or any state “blue sky” securities Laws, and the rules and regulations thereunder and (b) where
the failure to obtain or make such consents or to make such filings or notifications would not prevent, impede or, in any material respect,
delay or adversely affect the performance by such Company Shareholder of its obligations under this Agreement.

 

1.4            No-Conflict.
The execution, delivery and performance by such Company Shareholder of this Agreement do not and will not (a) if such Company
Shareholder is not an individual, contravene or conflict with or violate any provision of, or result in the breach of the
Organizational Documents of such Company Shareholder, (b) contravene or conflict with or result in a violation of any provision
of any Law, Permit or Governmental Order binding upon or applicable to such Company Shareholder or any of its properties or assets,
(c) violate, conflict with, result in a breach of any provision of or the loss of any benefit under, constitute a
default under, or result in the termination or acceleration of, or a right of termination, cancellation, modification, acceleration
or amendment under, accelerate the performance required by, any of the terms, conditions or provisions of any Contract to which such
Company Shareholder is a party, or (d) result in the creation or imposition of any Lien upon any of the properties or assets of
such Company Shareholder, except in the case of each of clauses (b) through (d) that would not prevent, impede or, in any
material respect, delay or adversely affect the performance by such Company Shareholder of its obligations under this Agreement.

 

    2 

     

    

  

1.5            Subject
Shares. As of the date hereof, such Company Shareholder is the beneficial and sole legal owner of its Subject Shares, and all such
Subject Shares are owned by such Company Shareholder free and clear of all liens or encumbrances, other than liens or encumbrances pursuant
to this Agreement, the other Transaction Agreements, the Organizational Documents of the Company, the agreements set forth on Schedule
B (the “Investment Agreements”), any applicable securities Laws or that would not, individually or in the aggregate,
reasonably be expected to prevent, delay or impair the ability of such Company Shareholder to perform its obligations under this Agreement
or the consummation of the Transactions. Such Company Shareholder does not legally own any Equity Securities of the Company other than
the Subject Shares. Such Company Shareholder has the sole right to vote the Subject Shares, and none of the Subject Shares is subject
to any voting trust or other agreement, arrangement or restriction with respect to the voting of the Subject Shares, except as contemplated
by (i) this Agreement, (ii) the other Transaction Agreements, (iii) the Organizational Documents of the Company, (iv) the
Investment Agreements, (v) any applicable securities Laws or (vi) that would not, individually or in the aggregate, reasonably
be expected to prevent, delay or impair the ability of such Company Shareholder to perform its obligations under this Agreement or the
consummation of the Transactions.

 

1.6            Acknowledgement.
Such Company Shareholder understands and acknowledges that each of the Company and SPAC are entering into the Merger Agreement in reliance
upon such Company Shareholder’s execution and delivery of this Agreement. Such Company Shareholder has received a copy of the Merger
Agreement and is familiar with the provisions of the Merger Agreement.

 

1.7            Absence
of Litigation. With respect to such Company Shareholder, as of the date hereof, there is no action, suit, investigation or proceeding
pending against, or, to the knowledge of such Company Shareholder, threatened against, such Company Shareholder or any of such Company
Shareholder’s properties or assets (including such Company Shareholder’s Subject Shares) that could reasonably be expected
to prevent, materially delay or materially impair the ability of such Company Shareholder to perform its obligations hereunder or to
consummate the transactions contemplated hereby.

 

1.8            Additional
Representations and Warranties of Individual Company Shareholder. Each Company Shareholder who is an individual severally and not
jointly hereby represents and warrants to the Company and SPAC that

 

 (a)            such
Company Shareholder is not a minor, and is of full age and sound mind.

 

 (b)            such
Company Shareholder (i) has such knowledge and experience in financial and business matters that he or she is capable of evaluating
the risks of the transactions contemplated by this Agreement and other Transaction Agreements; and (ii) has been given a copy of
the Transaction Agreements, is knowledgeable regarding the structure of the Transactions, including the basis and purpose of each of
the Transaction Agreements to which he or she is a party and the transactions contemplated thereby and the roles of each of the respective
parties thereto, and based on such information as the Company Shareholder has deemed appropriate, made its own analysis and decision
to enter into this Agreement.

 

    3 

     

    

  

Article II

Representations and Warranties of SPAC

 

SPAC hereby represents and warrants to each Company
Shareholder and the Company during the Exclusivity Period as follows:

 

2.1            Corporate
Organization. SPAC is an exempted company duly incorporated, is validly existing and is in good standing under the Laws of the Cayman
Islands and has the requisite corporate power and authority to own, lease or operate its assets and properties and to conduct its business
as it is now being conducted. SPAC is duly licensed or qualified and in good standing (where such concept is applicable) as a foreign
entity in each jurisdiction in which the ownership of its property or the character of its activities is such as to require it to be
so licensed or qualified, except where failure to be so licensed or qualified would not, individually or in the aggregate, reasonably
be expected to prevent or materially delay or materially impair the ability of SPAC to consummate the transactions contemplated hereby.

 

2.2            Due
Authorization. SPAC has all requisite corporate power and authority to execute and deliver this Agreement, to perform its obligations
hereunder and to consummate the transactions contemplated hereby. The execution, delivery and performance of this Agreement and the consummation
of the transactions contemplated hereby have been duly and validly authorized and approved by the board of directors of SPAC and no other
corporate or equivalent proceeding on the part of SPAC is necessary to authorize this Agreement or SPAC’s performance hereunder
(except that the SPAC Shareholder Approval is a condition to the consummation of the Mergers). This Agreement has been duly and validly
executed and delivered by SPAC and, assuming due authorization and execution by each other party hereto, this Agreement constitutes a
legal, valid and binding obligation of SPAC, enforceable against SPAC in accordance with its terms, subject to the Enforceability Exceptions.

 

2.3            No-Conflict.
Subject to the receipt of the consents, approvals, authorizations and other requirements set forth in Section 5.05 of the
Merger Agreement and obtaining the SPAC Shareholder Approval, the execution, delivery and performance by SPAC of this Agreement and
the consummation of the transactions by SPAC contemplated hereby do not and will not (a) contravene or conflict with or violate
any provision of, or result in the breach of the SPAC Organizational Documents, (b) contravene
or conflict with or result in a violation of any provision of any Law, Permit or Governmental Order binding upon or applicable to
SPAC or any of its properties or assets, (c) violate, conflict with, result in a breach of any provision of or the loss of any
benefit under, constitute a default under, or result in the termination or acceleration of, or a right of termination, cancellation,
modification, acceleration or amendment under, accelerate the performance required by, any of the terms, conditions or provisions of
any Contract to which SPAC is a party, or (d) result in the creation or imposition of any Lien upon any of the properties or
assets of SPAC (including the Trust Account), except in the case of each of clauses (b) through (d) that would not
prevent, impede or, in any material respect, delay or adversely affect the performance by SPAC of its obligations under this
Agreement.

 

    4 

     

    

  

Article III

Representations and Warranties of the Company

 

The Company hereby represents and warrants to
each Company Shareholder and SPAC during the Exclusivity Period as follows:

 

3.1            Corporate
Organization. The Company is an exempted company duly incorporated, is validly existing and is in good standing under the Laws of
the Cayman Islands and has the requisite corporate power and authority to own, lease or operate its assets and properties and to conduct
its business as it is now being conducted. The Company is duly licensed or qualified and in good standing (where such concept is applicable)
as a foreign entity in each jurisdiction in which the ownership of its property or the character of its activities is such as to require
it to be so licensed or qualified, except where the failure to be so licensed or qualified would not, individually or in the aggregate,
have a Material Adverse Effect.

 

3.2            Due
Authorization. The Company has the requisite corporate power and authority to execute and deliver this Agreement, (subject to the
consents, approvals, authorizations and other requirements described in Section 4.04 or Section 4.05 of the Merger Agreement)
to perform all obligations to be performed by it hereunder and to consummate the transactions contemplated hereby. The execution, delivery
and performance of this Agreement and the consummation of the transactions contemplated hereby have been duly authorized by the Company
Board and other than the consents, approvals, authorizations and other requirements described in Section 4.04 or Section 4.05
of the Merger Agreement, no other corporate proceeding on the part of the Company is necessary to authorize this Agreement or the Company’s
performance hereunder (except that the Company Shareholder Approval is a condition to the consummation of the Mergers). This Agreement
has been duly and validly executed and delivered by the Company and, assuming due and valid authorization, execution and delivery by
each other party hereto, this Agreement constitutes a valid and binding obligation of the Company, enforceable against the Company in
accordance with its terms, subject to the Enforceability Exceptions.

 

3.3            No-Conflict.
Subject to the receipt of the consents, approvals, authorizations, and other requirements set forth in Section 4.05 of the
Merger Agreement, the execution, delivery and performance by the Company of this Agreement and the consummation by the Company of
the transactions contemplated hereby do not and will not, (a) contravene or conflict with, or trigger shareholder rights
that have not been duly waived under, the Organizational Documents of the Company or any of its Subsidiaries, (b) contravene or
conflict with or constitute a violation of any provision of any Law, Permit or Governmental Order binding upon or applicable to the
Company or any of its Subsidiaries or any of their respective assets or properties, (c) violate,
conflict with, result in a breach of any provision of or the loss of any benefit under, constitute a default under, or result in the
termination or acceleration of, or a right of termination, cancellation, modification, acceleration or amendment under, accelerate
the performance required by, any of the terms, conditions or provisions of any Specified Contract or (d) result in the creation
or imposition of any Lien on any asset, property or Equity Security of the Company or any of its Subsidiaries (other than any
Permitted Liens), except in the case of clauses (b) through (d) above as would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect.

 

    5 

     

    

 

Article IV

Agreement to Vote

 

Each Company Shareholder covenants and agrees
during the Exclusivity Period:

 

4.1            Agreement
to Vote.

 

(a)            In
Favor of the Mergers. At any meeting of shareholders of the Company called to seek the Company Shareholder Approval, including the
Company Extraordinary General Meeting, or at any adjournment thereof, or in connection with any written consent of shareholders of the
Company or in any other circumstances upon which a vote, consent or other approval with respect to the Company Transaction Proposals
and any other transactions contemplated by the Merger Agreement and any other Transaction Agreements, such Company Shareholder shall
(i) if a meeting is held, appear at such meeting or otherwise cause the Subject Shares to be counted as present at such meeting
for purposes of establishing a quorum, and (ii) vote or cause to be voted (including by class vote and/or written consent, if applicable)
the Subject Shares in favor of granting the Company Shareholder Approval or, if there are insufficient votes in favor of granting the
Company Shareholder Approval, in favor of the adjournment of such meeting of shareholders of the Company to a later date.

 

(b)            Against
Other Transactions. At any meeting of shareholders of the Company or at any adjournment thereof, or in connection with any
written consent of shareholders of the Company or in any other circumstances upon which such Company Shareholder’s vote,
consent or other approval is sought, such Company Shareholder shall vote (or cause to be voted) the Subject Shares (including by
withholding class vote and/or written consent, if applicable) against (i) other than in connection with the Transactions, any
Alternative Transaction Proposal involving the Company and its Subsidiaries, (ii) allowing the Company to execute or enter
into, any agreement related to an Alternative Transaction Proposal, and (iii) entering into any agreement, or agreement in
principle requiring the Company to impede, abandon, terminate or fail to consummate the transactions contemplated by the Merger
Agreement or breach its obligations thereunder, which, in each of cases (i) and (iii) of this sentence, would be
reasonably likely to in any material respect impede, interfere with, delay or attempt to discourage, frustrate the purposes
of, result in a breach by the Company of, prevent or nullify any provision of the Merger Agreement or any other Transaction
Agreement, the Mergers or any other Transaction or change in any manner the voting rights of any class of the Company’s share
capital.

 

    6 

     

    

 

4.2            No
Transfer. From the date of this Agreement until the date of termination of this Agreement, such Company Shareholder shall not
(a) sell, offer to sell, contract or agree to sell, hypothecate, pledge, grant any option, right or warrant to purchase or
otherwise transfer, dispose of or agree to transfer or dispose of, directly or indirectly, or establish or increase a put equivalent
position or liquidate or decrease a call equivalent position within the meaning of Section 16 of the Exchange Act, and the
rules and regulations of the SEC promulgated thereunder, with respect to any Subject Share, (b) enter into any swap or
other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any Subject
Shares, whether any such transaction is to be settled by delivery of such securities, in cash or otherwise, or (c) publicly
announce any intention to effect any transaction specified in clause (a) or (b) (the actions specified in clauses
(a) to (c), collectively, “Transfer”), (ii) grant any proxies or powers of attorney or enter into any
voting arrangement, whether by proxy, voting agreement, voting trust, voting deed or otherwise (including pursuant to any loan of
Subject Shares), or enter into any other agreement, with respect to any Subject Shares, in each case, other than as set forth in the
Merger Agreement, other Transaction Agreements or the voting and other arrangements under the Organizational Documents of the
Company, (iii) take any action that would reasonably be expected to make any representation or warranty of such Company
Shareholder herein untrue or incorrect, or would reasonably be expected to have the effect of preventing or disabling such Company
Shareholder from performing its obligations hereunder, or (iv) commit or agree to take any of the foregoing actions.
Notwithstanding the foregoing, such Company Shareholder may make Transfers of such Company Shareholder’s Subject Shares
(i) pursuant to this Agreement, (ii) upon the consent of the Company and SPAC, (iii) between such Company Shareholder
and any of its Affiliates (and any of the Company Shareholder’s and its affiliates’ respective executive officers and
directors) (provided that such Affiliate shall enter into a written agreement, in form and substance reasonably satisfactory
to the Company and SPAC, agreeing to be bound by this Agreement to the same extent as such Company Shareholder was with respect to
such transferred Subject Shares), (iv) in the case of an individual, by gift to a member of one of the individual’s
immediate family, to a trust, the beneficiary of which is a member of the individual’s immediate family or an affiliate of
such person, (v) in the case of an individual, by virtue of laws of descent and distribution upon death of the individual,
(vi) in the case of an individual, pursuant to a qualified domestic relations order, (vii) in the case of an individual,
pursuant to a charitable gift or contribution, and (viii) by virtue of such Company Shareholder’s Organizational
Documents upon liquidation or dissolution of such Company Shareholder, so long as, in each case of clauses (i) through (viii),
the power to vote (including, without limitation, by proxy or power of attorney) and otherwise fulfill such Company
Shareholder’s obligations under this Agreement and the Merger Agreement is not relinquished or prior to and as a condition to
the effectiveness of any such Transfer (provided that such transferee shall enter into a written agreement, in form and
substance reasonably satisfactory to the Company and SPAC, agreeing to be bound by this Agreement to the same extent as such Company
Shareholder was with respect to such transferred Subject Shares); provided, in the case of clauses (v), (vi), and (viii), the
transferee will not be required to assume voting obligations if the transferee’s assumption of such obligations would violate
any applicable Laws, including any securities Laws, or would reasonably be expected to materially delay or impede the
Registration Statement or Proxy Statement being declared effective under the Securities Act. Any action attempted to be taken in
violation of the preceding sentence will be null and void. Such Company Shareholder agrees with, and covenants to, the Company and
SPAC that such Company Shareholder shall not request the Company to register the Transfer (by book-entry or otherwise) of any
certificated or uncertificated interest representing any of the Subject Shares.

 

    7 

     

    

  

4.3            Waiver
of Dissenters’ Rights. Such Company Shareholder hereby irrevocably waives, and agrees not to exercise or assert, any dissenters’
rights under Section 238 of the Cayman Companies Act and any other similar statute in connection with the Mergers and the Merger
Agreement.

 

4.4            No
Redemption. Such Company Shareholder irrevocably and unconditionally agrees that, from the date hereof and until the termination
of this Agreement, such Company Shareholder shall not elect to cause the Company to redeem any Subject Shares now or at any time legally
or beneficially owned by such Company Shareholder, or submit or surrender any of its Subject Shares for redemption, in connection with
the Transactions, other than as contemplated under Section 2.01(b)(i) of the Merger Agreement or to exercise any such repurchase
option or other right set forth in the applicable agreement governing such Company Restricted Shares on the same terms as applicable
to such Company Restricted Shares as of immediately prior to the First Effective Time.

  

4.5            New
Shares. In the event that prior to the Closing (i) any Pre-Subdivision Shares, Company Ordinary Shares, Company Series C
Preferred Shares or other securities are issued or otherwise distributed to a Company Shareholder pursuant to any stock dividend or distribution,
or any change in any of the Pre-Subdivision Shares, Company Ordinary Shares, Company Series C Preferred Shares or other share capital
of the Company by reason of any stock split-up, recapitalization, combination, exchange of shares or the like, including any shares received
pursuant to the Share Subdivision, (ii) a Company Shareholder acquires legal or beneficial ownership of any Pre-Subdivision Shares,
Company Ordinary Shares or Company Series C Preferred Shares after the date of this Agreement, including upon exercise of options,
settlement or restricted share units or capitalization of working capital loans, or (iii) a Company Shareholder acquires the right
to vote or share in the voting of any Pre-Subdivision Share, Company Ordinary Share or Company Series C Preferred Shares after the
date of this Agreement (collectively, the “New Securities”), the terms “Subject Shares” shall be deemed to refer
to and include such New Securities (including all such stock dividends and distributions and any securities into which or for which any
or all of the Subject Shares may be changed or exchanged into).

 

4.7            Restricted
Activities. Such Company Shareholder shall not adopt or enter into a plan of complete or partial liquidation, dissolution,
merger, consolidation, restructuring, recapitalization or other reorganization without the prior written consent of the Company and
SPAC, except by virtue of such Company Shareholder’s Organizational Documents upon liquidation or dissolution of such
Company Shareholder, so long as, the power to vote (including, without limitation, by proxy or power of attorney) and otherwise
fulfill such Company Shareholder’s obligations under this Agreement and the Merger Agreement is not relinquished or prior to
and as a condition to the effectiveness of any such Transfer (provided that such transferee shall enter into a written
agreement, in form and substance reasonably satisfactory to the Company and SPAC, agreeing to be bound by this Agreement to the same
extent as such Company Shareholder was with respect to such transferred Subject Shares).

 

    8 

     

    

 

Article V

Certain Other Covenants of Company Shareholders

 

5.1            Investment
Agreements.

 

(a)            With
respect to each Investment Agreement, the Company Shareholders and the Company hereby agree that from the date hereof until the earlier
of (x) termination of this Agreement and (y) termination of such Investment Agreement pursuant to Section 5.1(b),
none of them shall, or shall agree to, amend, modify or vary such Investment Agreement.

  

(b)            Each
of the Company Shareholders and the Company hereby agrees that, in accordance with the terms thereof, (i) the Investment Agreements,
(ii) any rights of such Company Shareholder under the Investment Agreements and (iii) any rights under any other agreement
providing for redemption rights, put rights, purchase rights or other similar rights not generally available to the shareholders of the
Company, shall be terminated effective as of the First Effective Time, and thereupon shall be of no further force or effect, without
any further action on the part of any of the Company Shareholders or the Company, and neither the Company, the Company Shareholders,
nor any of their respective affiliates or subsidiaries shall have any further rights, duties, liabilities or obligations thereunder.

 

5.2            Additional
Matters. Each Company Shareholder shall, from time to time, (i) execute and deliver, or cause to be executed and delivered,
such additional or further consents, documents and other instruments as the Company or SPAC may reasonably request for the purpose of
effectively consummating the transactions contemplated by this Agreement, the Merger Agreement and the other Transaction Agreements and
(ii) refrain from exercising any veto right, consent right or similar right (whether under the Organizational Documents of the Company
or the Cayman Companies Act) which would prevent, impede or, in any material respect, delay or adversely affect the consummation of the
Mergers or any other Transaction.

 

5.3            Waiver
of Certain Company Shareholders’ Rights. To the extent applicable to a Company Shareholder, such Company Shareholder hereby
irrevocably waives and agrees not to exercise any rights he, she or it may have under the Amended and Restated Memorandum and Articles
of Association of the Company adopted by a special resolutions of shareholders of the Company dated July 29, 2020 in connection
with the Mergers and other transactions contemplated by the Merger Agreement and the other Transaction Agreements.

  

5.4            Exclusivity
and Confidentiality. Each Company Shareholder shall be bound by and comply with Section 8.03(a) (Exclusivity) and
Section 8.05(b) (Confidentiality; Publicity) of the Merger Agreement (and any relevant definitions contained in any
such sections) as if (a) such Company Shareholder was an original signatory to the Merger Agreement with respect to such provisions,
and (b) each reference to the “Company” contained in Section 8.03(a) of the Merger Agreement (other than Section 8.03(a)(i) or
for purposes of the definition of Alternative Transaction Proposal) and “Affiliates” contained in Section 8.05(b) of
the Merger Agreement also referred to such Company Shareholder.

 

5.5            Consent
to Disclosure. Each Company Shareholder consents to and authorizes the Company or SPAC, as applicable, to publish and disclose in
all documents and schedules filed with the SEC or any other Governmental Entity or applicable securities exchange, and any press release
or other disclosure document that the Company or SPAC, as applicable, reasonably determines to be necessary or advisable in connection
with the Mergers or any other transactions contemplated by the Merger Agreement or this Agreement, such Company Shareholder’s identity
and shareholding in the Company, the existence of this Agreement and the nature of such Company Shareholder’s commitments and obligations
under this Agreement, and each Company Shareholder acknowledges that the Company or SPAC may, in their sole discretion, file this Agreement
or a form hereof with the SEC or any other Governmental Entity or securities exchange to promptly give the Company or SPAC, as applicable,
any information that is in its possession that the Company or SPAC, as applicable, may reasonably request for the preparation of any
such disclosure documents, and each Company Shareholder agrees to promptly notify the Company and SPAC of any required corrections with
respect to any written information supplied by it specifically for use in any such disclosure document, if and to the extent that such
Company Shareholder shall become aware that any such information shall have become false or misleading in any material respect.

 

    9 

     

    

  

Article VI

General Provisions

 

6.1            Termination.
This Agreement shall be effective from the date hereof and shall terminate automatically and become void and of no further force or effect,
without any notice or other action by any Person, upon the earliest of (a) as to a Company Shareholder, the mutual written consent
of the Company, such Company Shareholder and SPAC, (b) the termination of the Merger Agreement in accordance with its terms and
(c) the Closing, provided that, in the event that the Merger Agreement is not terminated pursuant to its terms prior to the
Closing, Articles I through IV shall terminate upon the Closing but Article V (for Section 5.4,
solely with respect to 8.05(b) (Confidentiality; Publicity) of the Merger Agreement) shall survive indefinitely. The termination
of this Agreement shall not relieve any party from any liability arising in respect of any willful and material breach of this Agreement
prior to such termination. Upon the termination of this Agreement (or any portion thereof), this Article VI shall survive
indefinitely.

 

6.2            Capacity
as a Company Shareholder. Each Company Shareholder signs this Agreement solely in such Company Shareholder’s capacity as a
shareholder of the Company, and not in such Company Shareholder’s capacity as a director or officer of the Company, if applicable.

 

6.3            Notice.
All notices and other communications hereunder shall be in writing and shall be deemed to have been duly given (i) when delivered
in person, (ii) when delivered after posting in the United States mail having been sent registered or certified mail return receipt
requested, postage prepaid, (iii) when delivered by FedEx or other nationally recognized overnight delivery service or (iv) when
e-mailed during normal business hours (and otherwise as of the immediately following Business Day) to the Company and SPAC in accordance
with Section 11.02 of the Merger Agreement and to each Company Shareholder at its address set forth set forth on Schedule A
hereto (or at such other address for a party as shall be specified by like notice).

 

6.4            Entire
Agreement; Amendment. This Agreement (together with the Schedules and Exhibits to this Agreement) constitutes the entire agreement
and understanding between the parties hereto relating to the subject matter hereof and the transactions contemplated hereby and supersedes
any other agreements and understandings, whether written or oral, that may have been made or entered into by or between the parties hereto
relating to the subject matter hereof or the transactions contemplated hereby. This Agreement may not be changed, amended, modified or
waived (other than to correct a typographical error) as to any particular provision, except by a written instrument executed by all parties
hereto.

 

    10 

     

    

 

6.5            Assignment.
No party hereto shall assign this Agreement or any part hereof without the prior written consent of the other parties hereto, except
that, for the avoidance of doubt, in connection with a Transfer of any Subject Shares in accordance with the terms of this Agreement,
transferee to whom such Subject Shares are transferred shall thenceforth be entitled to all the rights and be subject to all the obligations
under this Agreement; provided, that no such assignment shall relieve the assigning party of its obligations hereunder. Subject
to the foregoing, this Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors
and permitted assigns. Any attempted assignment in violation of the terms of this Section 6.5 shall be null and void, ab
initio. For the avoidance of doubt, no Transfer of Pre-Subdivision Shares, Company Ordinary Shares or Company Series C Preferred
Shares shall be (or be deemed to be) an assignment of this Agreement or the rights or obligations hereunder.

  

6.6            Governing
Law. This Agreement shall be governed by, and construed in accordance with, the internal substantive Laws of the State of
Delaware applicable to contracts entered into and to be performed solely within such state, without giving effect to principles or
rules of conflict of laws to the extent such principles or rules would require or permit the application of Laws of
another jurisdiction. Any dispute, controversy, difference, or claim arising out of or relating to this Agreement, including its
existence, validity, interpretation, performance, breach, or termination, or any dispute regarding non-contractual obligations
arising out of or relating to this Agreement, shall be referred to and finally resolved by arbitration administered by the Hong Kong
International Arbitration Centre (“HKIAC”) under the HKIAC Administered Arbitration Rules in force when the
Notice of Arbitration is submitted. The seat of arbitration shall be Hong Kong. There shall be three arbitrators. The arbitration
proceedings shall be conducted in English. The law of this arbitration clause shall be Hong Kong law. For the avoidance of doubt, a
request by a party hereto to a court of competent jurisdiction for interim measures necessary to preserve such party’s
rights, including pre-arbitration attachments, injunctions, or other equitable relief, shall not be deemed incompatible with, or a
waiver of, the agreement to arbitrate in this Section 6.6.

 

6.7            Enforcement.
Each of the parties hereto agrees that irreparable damage for which monetary damages, even if available, would not be an adequate remedy,
would occur in the event that the parties do not perform their obligations under the provisions of this Agreement (including failing
to take such actions as are required of them hereunder to consummate this Agreement) in accordance with its specified terms or otherwise
breach such provisions. The parties acknowledge and agree that (i) the parties shall be entitled to an injunction, specific performance,
or other equitable relief, to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof, without
proof of damages, prior to the valid termination of this Agreement in accordance with Section 6.1, this being in addition
to any other remedy to which they are entitled under this Agreement, and (ii) the right of specific enforcement is an integral part
of the transactions contemplated by this Agreement and without that right, none of the parties would have entered into this Agreement.
Each party agrees that it will not allege, and each party hereby waives the defense, that the other parties have an adequate remedy at
Law or that an award of specific performance is not an appropriate remedy for any reason at Law or equity. The parties acknowledge and
agree that any party seeking an injunction to prevent breaches of this Agreement and to enforce specifically the terms and provisions
of this Agreement in accordance with this Section 6.7 shall not be required to provide any bond or other security in connection
with any such injunction.

  

6.8            Counterparts.
This Agreement may be executed in two or more counterparts (any of which may be delivered by electronic transmission), each of which
shall constitute an original, and all of which taken together shall constitute one and the same instrument. Delivery by email to counsel
for the other parties of a counterpart executed by a party shall be deemed to meet the requirements of the previous sentence.

  

[Signature pages follow]

 

    11 

     

    

 

 

IN WITNESS WHEREOF, the parties
hereto have hereunto caused this Agreement to be duly executed as of the date hereof.

 

	 	GOGORO INC.
	 	 
	 	By:	 
	 	Name: 
	 	Title:

 

[Signature Page to Company Shareholder Voting Agreement]

 

     

     

    

 

IN WITNESS WHEREOF, the parties
hereto have hereunto caused this Agreement to be duly executed as of the date hereof.

 

	 	POEMA GLOBAL HOLDINGS CORP.
	 	 
	 	By: 	 
	 	Name: Joaquin Rodriguez Torres 
	 	Title: Co-Chairman
	 	 
	 	By: 	 
	 	Name: Homer Sun 
	 	Title: CEO

 

[Signature Page to Company
Shareholder Voting Agreement]

 

     

     

    

 

IN WITNESS WHEREOF, the parties
hereto have hereunto caused this Agreement to be duly executed as of the date hereof.

 

	 	[COMPANY SHAREHOLDER]
	 	 
	 	By: 	 
	 	Name: 
	 	Title:

 

[Signature
Page to Company Shareholder Voting Agreement]

 

     

     

    

 

Schedule A

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    Schedule A

     

    

 

Schedule B

 

	1.	Shareholders Agreement between the Company, Samuel Yin, Cher Wang, and Horace Luke dated May 3, 2013.

 

	2.	The following agreements:

 

		a)	Investor’s Rights Agreement between the Company Samuel Yin, Cher Wang, Horace Luke, and Carnival
Holdings Limited dated October 1, 2015

 

		b)	Investor’s Rights Agreement between the Company and Far Eastern International Bank in its capacity
as Master Custodian of Fuh Hwa Smart Energy Fund date April 18, 2017

 

		c)	Investor’s Rights Agreement between the Company and Chang Chun Investment Co., Ltd. dated March 28,
2017

 

		d)	Investor’s Rights Agreement between the Company and Huei Hong Investment Co., Ltd. dated March 28,
2017

 

		e)	Investor’s Rights Agreement between the Company and Ying Jia Investment Co. Ltd., dated March 28,
2017

 

		f)	Investor’s Rights Agreement between the Company and Anderson Investments PTE. Ltd., dated March 28,
2017

 

		g)	Investor’s Rights Agreement between the Company and Ellpis Investments Limited dated March 28,
2017

 

		h)	Investor’s Rights Agreement between the Company and Rainbow Star Group Limited dated March 28,
2017

 

		i)	Investor’s Rights Agreement between the Company and Tuscany Capital Holding Ltd. dated April 18,
2017

 

		j)	Investor’s Rights Agreement between the Company and Engie New Ventures S.A., dated May 17,
2017

 

		k)	Investor’s Rights Agreement between the Company and Soaring Elite Limited dated May 23, 2017

 

		l)	Investor’s Rights Agreement between the Company and Generation IM Climate Solutions Fund II, L.P.,
dated June 6, 2017

 

		m)	Investor’s Rights Agreement between the Company and Acbel Polytech Inc., dated May 23, 2017

 

		n)	Investor’s Rights Agreement between the Company and Sheng Cheng Investment Co., Ltd., dated
March 28, 2017

 

    Schedule BExhibit 10.6

 

Agreed Form

 

ASSIGNMENT AND ASSUMPTION AGREEMENT

 

This
ASSIGNMENT AND ASSUMPTION AGREEMENT (this “Agreement”), is made and entered into as of [●], 202[●] (the
 “Effective Date”), by and among Gogoro Inc., an exempted company incorporated with limited liability under the
Laws of Cayman Islands (the “Company”), Poema Global Holdings Corp., an exempted company incorporated with limited
liability under the Laws of Cayman Islands (“SPAC”), and Continental Stock Transfer & Trust Company, a New
York corporation, as warrant agent (in such capacity, the “Warrant Agent”).

 

WHEREAS,
SPAC and the Warrant Agent are parties to that certain Warrant Agreement, dated as of January 5, 2021 (the “Existing Warrant
Agreement”);

 

WHEREAS,
SPAC issued (i) 17,250,000 warrants as part of the units offered in its initial public offering (the “Public Warrants”)
and (ii) 9,400,000 warrants to Poema Global Partners LLC, a Cayman Islands limited liability company (the “Sponsor”)
in a concurrent private placement (the “Private Placement Warrants”) pursuant to that certain Private Placement Warrants
Purchase Agreement, dated as of January 5, 2021, in each case, on the terms and conditions set forth in the Existing Warrant Agreement;

 

WHEREAS,
on September 16, 2021, the Company, Starship Merger Sub I Limited, an exempted company incorporated with limited liability under the Laws
of Cayman Islands and a wholly-owned subsidiary of the Company (“Merger Sub”), Starship Merger Sub II Limited, an exempted
company incorporated with limited liability under the Laws of Cayman Islands and a wholly-owned subsidiary of the Company (“Merger
Sub II”) and SPAC entered into that certain Agreement and Plan of Merger (the “Merger Agreement”), pursuant
to which, among other things, (i) Merger Sub will merge with and into SPAC (the “First Merger”), with SPAC surviving
the First Merger as a wholly owned subsidiary of the Company, and (ii) SPAC will merge with and into Merger Sub II (the “Second
Merger” and together with the First Merger, the “Mergers”), with Merger Sub II surviving the Second Merger
as a wholly owned subsidiary of the Company;

 

WHEREAS,
upon consummation of the Mergers, as provided in Section 4.5 of the Existing Warrant Agreement, (i) the Public Warrants and
Private Placement Warrants will no longer be exercisable for Class A ordinary shares of SPAC, par value $0.0001 per share (the “SPAC
Class A Shares”), but instead will be exercisable (subject to the terms and conditions of the Existing Warrant Agreement
as amended hereby) for a number of ordinary shares of the Company, par value $0.0001 per share (the “Ordinary Shares”),
equal to the number of SPAC Class A Shares for which such warrants were exercisable immediately prior to the Mergers, subject to
adjustment as described herein (such warrants as so adjusted and amended, the “Warrants”) and (ii) the Warrants
shall be assumed by the Company;

 

WHEREAS,
in connection with the transactions contemplated by the Merger Agreement, SPAC desires to assign to the Company, and the Company desires
to assume, all of SPAC’s rights, interests and obligations under the Existing Warrant Agreement;

 

     

     

    

 

WHEREAS,
the consummation of the transactions contemplated by the Merger Agreement will constitute a Business Combination as defined in the Existing
Warrant Agreement;

 

WHEREAS,
Section 9.8 of the Existing Warrant Agreement provides that SPAC and the Warrant Agent may amend the Existing Warrant Agreement without
the consent of any Registered Holder (as defined below) for the purpose of (i) curing any ambiguity or correcting any defective provision
or mistake contained therein, including to conform the provisions thereof to the description of the terms of the Warrants and the Existing
Warrant Agreement set forth in the registration statements on Form S-1, File No. 333-251466 and 333-251907, and a prospectus
(the “Prospectus”) filed by SPAC with the Securities and Exchange Commission (the “Commission”),
or defective provision contained therein, and (ii) adding or changing any provisions with respect to matters or questions arising
under the Existing Warrant Agreement as the parties may deem necessary or desirable and that the parties deem shall not adversely affect
the rights of the Registered Holders thereunder;

 

WHEREAS,
the Company desires the Warrant Agent to act on behalf of the Company, and the Warrant Agent is willing to so act, in connection with
the issuance, registration, transfer, exchange, redemption and exercise of the Warrants;

 

WHEREAS,
the Company desires to provide for the form and provisions of the Warrants, the terms upon which they shall be issued and exercised, and
the respective rights, limitation of rights, and immunities of the Company, the Warrant Agent and the holders of the Warrants; and

 

WHEREAS,
all acts and things have been done and performed which are necessary to make the Warrants, when executed on behalf of the Company and
countersigned by or on behalf of the Warrant Agent (if a physical certificate is issued), as provided herein, the valid, binding and legal
obligations of the Company, and to authorize the execution and delivery of this Agreement.

 

NOW,
THEREFORE, in consideration of the mutual agreements herein contained, the receipt and sufficiency of which is hereby acknowledged,
and intending to be legally bound, the parties hereto agree as follows:

 

1.           Assignment
and Assumption; Amendment; Appointment of Warrant Agent.

 

1.1         Assignment
and Assumption. SPAC hereby assigns to the Company all of SPAC’s right, title and interest in and to the Existing Warrant Agreement
and the Warrants (each as amended hereby) as of the Closing (as defined in the Merger Agreement). The Company hereby assumes, and agrees
to pay, perform, satisfy and discharge in full, as the same become due, all of SPAC’s liabilities and obligations under the Existing
Warrant Agreement and the Warrants (each as amended hereby) arising from and after the Closing.

 

1.2         Amendment.
SPAC and the Warrant Agent hereby amend and restate the Existing Warrant Agreement and the Public Warrants and Private Placement Warrants
issued thereunder in accordance with Section 9.8 of the Existing Warrant Agreement, in its entirety in the form of this Agreement
as of the Closing.

 

    2

     

    

 

1.3         Appointment
of Warrant Agent. The Company hereby appoints the Warrant Agent to act as agent for the Company for the Warrants, and the Warrant
Agent hereby accepts such appointment and agrees to perform the same in accordance with the terms and conditions set forth in this Agreement.

 

2.            Warrants.

 

2.1         Form of
Warrant. Each Warrant shall initially be issued in registered form only.

 

2.2         Effect
of Countersignature. If a physical certificate is issued, unless and until countersigned by the Warrant Agent pursuant to this Agreement,
a certificated Warrant shall be invalid and of no effect and may not be exercised by the holder thereof.

 

2.3         Registration.

 

2.3.1      Warrant
Register. The Warrant Agent shall maintain books (the “Warrant Register”), for the registration of original issuance
and the registration of transfer of the Warrants. Upon the initial issuance of the Warrants in book-entry form, the Warrant Agent shall
issue and register the Warrants in the names of the respective holders thereof in such denominations and otherwise in accordance with
instructions delivered to the Warrant Agent by the Company. Ownership of beneficial interests in the Public Warrants shall be shown on,
and the transfer of such ownership shall be effected through, records maintained by institutions that have accounts with The Depository
Trust Company (the “Depositary”) (such institution, with respect to a Warrant in its account, a “Participant”).

 

If the Depositary subsequently
ceases to make its book-entry settlement system available for the Public Warrants, the Company may instruct the Warrant Agent regarding
making other arrangements for book-entry settlement. In the event that the Public Warrants are not eligible for, or it is no longer necessary
to have the Public Warrants available in, book-entry form, the Warrant Agent shall provide written instructions to the Depositary to deliver
to the Warrant Agent for cancellation each book-entry Public Warrant, and the Company shall instruct the Warrant Agent to deliver to the
Depositary definitive certificates in physical form evidencing such Warrants, which shall be in the form annexed hereto as Exhibit A.

 

Physical certificates, if
issued, shall be signed by, or bear the facsimile signature of, the Chairman of the Board, Co-Chairman, Chief Executive Officer or other
principal officer of the Company. In the event the person whose facsimile signature has been placed upon any Warrant shall have ceased
to serve in the capacity in which such person signed the Warrant before such Warrant is issued, it may be issued with the same effect
as if he or she had not ceased to be such at the date of issuance.

 

2.3.2       Registered
Holder. Prior to due presentment for registration of transfer of any Warrant, the Company and the Warrant Agent may deem and treat
the person in whose name such Warrant is registered in the Warrant Register (the “Registered Holder”) as the absolute
owner of such Warrant and of each Warrant represented thereby, for the purpose of any exercise thereof, and for all other purposes, and
neither the Company nor the Warrant Agent shall be affected by any notice to the contrary.

 

    3

     

    

 

2.4         Fractional
Warrants. The Company shall not issue fractional Warrants. If a holder of Warrants would be entitled to receive a fractional Warrant,
the Company shall round down to the nearest whole number the number of Warrants to be issued to such holder.

 

2.5         Private
Placement Warrants.

 

2.5.1      The
Private Placement Warrants shall be identical to the Public Warrants, except that so long as they are held by the Sponsor or any of
its Permitted Transferees (as defined below) the Private Placement Warrants: (i) may be exercised for cash or on a
 “cashless basis,” pursuant to subsection 3.3.1(c) hereof, (ii) including the Ordinary Shares issuable
upon exercise of the Private Placement Warrants, may not be transferred, assigned or sold until thirty (30) days after the Effective
Date, (iii) shall not be redeemable by the Company pursuant to Section 6.1 hereof and (iv) shall only be
redeemable by the Company pursuant to Section 6.2 if the Reference Value (as defined below) is less than $18.00 per
share (subject to adjustment in compliance with Section 4 hereof); provided, however, that in the case of
(ii), subject to that certain Sponsor Support Agreement, dated as of September 16, 2021, by and among, the Company, SPAC and the
Sponsor, the Private Placement Warrants and any Ordinary Shares issued upon exercise of the Private Placement Warrants may be
transferred by the holders thereof:

 

(a)            to
Sponsor’s officers or directors, any affiliates or family members of any of Sponsor’s officers or directors, any members or
partners of the Sponsor or their affiliates, any affiliates of the Sponsor, or any employees of such affiliates;

 

(b)           in
the case of an individual, by gift to a member of the individual’s immediate family or to a trust, the beneficiary of which is
a member of the individual’s immediate family, an affiliate of such person or to a charitable organization;

 

(c)            in
the case of an individual, by virtue of laws of descent and distribution upon death of the individual;

 

(d)            in
the case of an individual, pursuant to a qualified domestic relations order;

 

(e)            by
private sales or transfers made in connection with any forward purchase agreement or similar arrangement at prices no greater than the
price at which the Private Placement Warrants or Ordinary Shares, as applicable, were originally purchased;

 

(f)             by
virtue of the Sponsor’s organizational documents upon liquidation or dissolution of the Sponsor; or

 

    4

     

    

 

(g)            in
the event of the Company’s completion of a liquidation, merger, share exchange or other similar transaction which results in all
of the public shareholders having the right to exchange their Ordinary Shares for cash, securities or other property subsequent to the
Effective Date; provided, however, that, in the case of clauses (a) through (f), these permitted transferees
(the “Permitted Transferees”) must enter into a written agreement with the Company agreeing to be bound by the transfer
restrictions in this Agreement.

 

3.           Terms
and Exercise of Warrants.

 

3.1         Warrant
Price. Each whole Warrant shall entitle the Registered Holder thereof, subject to the provisions of such Warrant and of this Agreement,
to purchase from the Company the number of Ordinary Shares stated therein, at the price of $11.50 per share, subject to the adjustments
provided in Section 4 hereof and in the second to last sentence of this Section 3.1. The term “Warrant
Price” as used in this Agreement shall mean the price per share (including in cash or by payment of Warrants pursuant to a
 “cashless exercise,” to the extent permitted hereunder) described in the prior sentence at which Ordinary Shares may be purchased
at the time a Warrant is exercised. The Company in its sole discretion may lower the Warrant Price at any time prior to the Expiration
Date (as defined below) for a period of not less than fifteen (15) Business Days (unless otherwise required by the Commission, any national
securities exchange on which the Warrants are listed or applicable law); provided that the Company shall provide at least five
(5) days’ prior written notice of such reduction to the Registered Holders of the Warrants; and provided further, that
any such reduction shall be identical among all of the Warrants. “Business Day” means a day other than a Saturday,
Sunday or federal holiday, on which banks in New York City are generally open for normal business.

 

3.2         Duration
of Warrants. A Warrant may be exercised only during the period (the “Exercise Period”) (A) commencing on
the date that is thirty (30) days after the Effective Date, and (B) terminating at the earliest to occur of (x) 5:00 p.m.,
New York City time on the date that is five (5) years after the Effective Date, and (y) other than with respect to the Private
Placement Warrants then held by the Sponsor or its Permitted Transferees with respect to a redemption pursuant to Section 6.1
hereof or, if the Reference Value equals or exceeds $18.00 per share (subject to adjustment in compliance with Section 4
hereof), Section 6.2 hereof, 5:00 p.m., New York City time on the Redemption Date (as defined below) as provided in Section 6.3
hereof (the “Expiration Date”); provided, however, that the exercise of any Warrant shall be subject
to the satisfaction of any applicable conditions, as set forth in subsection 3.3.2 below, with respect to an effective registration
statement or a valid exemption therefrom being available. Except with respect to the right to receive the Redemption Price (as defined
below) (other than with respect to a Private Placement Warrant then held by the Sponsor or its Permitted Transferees in connection with
a redemption pursuant to Section 6.1 hereof or, if the Reference Value equals or exceeds $18.00 per share (subject to adjustment
in compliance with Section 4 hereof), Section 6.2 hereof), in the event of a redemption (as set forth in Section 6
hereof), each Warrant (other than a Private Placement Warrant then held by the Sponsor or its Permitted Transferees in the event
of a redemption pursuant to Section 6.1 hereof or, if the Reference Value equals or exceeds $18.00 per share (subject to
adjustment in compliance with Section 4 hereof), Section 6.2 hereof) not exercised on or before the Expiration
Date shall become void, and all rights thereunder and all rights in respect thereof under this Agreement shall cease at 5:00 p.m. New
York City time on the Expiration Date. The Company in its sole discretion may extend the duration of the Warrants by delaying the Expiration
Date; provided that the Company shall provide at least twenty (20) days prior written notice of any such extension to the Registered
Holders of the Warrants and, provided further that any such extension shall be identical in duration among all the Warrants.

 

    5

     

    

 

3.3         Exercise
of Warrants.

 

3.3.1      Payment.
Subject to the provisions of the Warrant and this Agreement, a Warrant may be exercised by the Registered Holder thereof by delivering
to the Warrant Agent at its corporate trust department (i) the Definitive Warrant Certificate evidencing the Warrants to be exercised,
or, in the case of a Warrant represented by a book-entry, the Warrants to be exercised (the “Book-Entry Warrants”)
on the records of the Depositary to an account of the Warrant Agent at the Depositary designated for such purposes in writing by the Warrant
Agent to the Depositary from time to time, (ii) an election to purchase (the “Election to Purchase”) any Ordinary
Shares pursuant to the exercise of a Warrant, properly completed and executed by the Registered Holder on the reverse of the Definitive
Warrant Certificate or, in the case of a Book-Entry Warrant, properly delivered by the Participant in accordance with the Depositary’s
procedures, and (iii) the payment in full of the Warrant Price for each Ordinary Share as to which the Warrant is exercised and any
and all applicable taxes due in connection with the exercise of the Warrant, the exchange of the Warrant for the Ordinary Shares and the
issuance of such Ordinary Shares, as follows:

 

(a)            by
wire transfer of immediately available funds, in good certified check or good bank draft payable to the order of the Warrant Agent;

 

(b)            [Reserved];

 

(c)            with
respect to any Private Placement Warrant, so long as such Private Placement Warrant is held by the Sponsor or a Permitted Transferee,
by surrendering the Warrants for that number of Ordinary Shares equal to (i) if in connection with a redemption of Private Placement
Warrants pursuant to Section 6.2 hereof, as provided in Section 6.2 hereof with respect to a Make-Whole Exercise
(as defined below) and (ii) in all other scenarios the quotient obtained by dividing (x) the product of the number of Ordinary
Shares underlying the Warrants, multiplied by the excess of the Sponsor Exercise Fair Market Value (as defined in this subsection 3.3.1(c))
over the Warrant Price by (y) the Sponsor Exercise Fair Market Value. Solely for purposes of this subsection 3.3.1(c), the
 “Sponsor Exercise Fair Market Value” shall mean the average last reported sale price of the Ordinary Shares for the
ten (10) trading days ending on the third (3rd) trading day prior to the date on which notice of exercise of the Private Placement
Warrant is sent to the Warrant Agent;

 

    6

     

    

 

(d)            as
provided in Section 6.2 hereof with respect to a Make-Whole Exercise; or

 

(e)            as
provided in Section 7.4 hereof.

 

3.3.2       Issuance
of Ordinary Shares on Exercise. As soon as practicable after the exercise of any Warrant and the clearance of the funds in payment
of the Warrant Price (if payment is pursuant to subsection 3.3.1(a)), the Company shall issue to the Registered Holder of such
Warrant a book-entry position or certificate, as applicable, for the number of Ordinary Shares to which he, she or it is entitled, registered
in such name or names as may be directed by him, her or it on the register of members of the Company, and if such Warrant shall not have
been exercised in full, a new book-entry position or countersigned Warrant, as applicable, for the number of Ordinary Shares as to which
such Warrant shall not have been exercised. Notwithstanding the foregoing, the Company shall not be obligated to deliver any Ordinary
Shares pursuant to the exercise of a Warrant and shall have no obligation to settle such Warrant exercise unless a registration statement
under the Securities Act with respect to the Ordinary Shares underlying the Public Warrants is then effective and a prospectus relating
thereto is current, subject to the Company’s satisfying its obligations under Section 7.4 or a valid exemption from
registration is available. No Warrant shall be exercisable and the Company shall not be obligated to issue Ordinary Shares upon exercise
of a Warrant unless the Ordinary Shares issuable upon such Warrant exercise have been registered, qualified or deemed to be exempt from
registration or qualification under the securities laws of the state of residence of the Registered Holder of the Warrants. Subject to
Section 4.6 of this Agreement, a Registered Holder of Warrants may exercise its Warrants only for a whole number of Ordinary
Shares. The Company may require holders of Public Warrants to settle the Warrant on a “cashless basis” pursuant to Section 7.4.
If, by reason of any exercise of Warrants on a “cashless basis”, the holder of any Warrant would be entitled, upon the exercise
of such Warrant, to receive a fractional interest in an Ordinary Share, the Company shall round down to the nearest whole number, the
number of Ordinary Shares to be issued to such holder.

 

3.3.3      Valid
Issuance. All Ordinary Shares issued upon the proper exercise of a Warrant in conformity with this Agreement and the Company’s
amended and restated memorandum and articles of association, as amended from time to time shall be validly issued, fully paid and non-assessable.

 

3.3.4      Date
of Issuance. Each person in whose name any book-entry position or certificate, as applicable, for Ordinary Shares is issued and who
is registered in the register of members of the Company shall for all purposes be deemed to have become the holder of record of such
Ordinary Shares on the date on which the Warrant, or book-entry position representing such Warrant, was surrendered and payment of the
Warrant Price was made, irrespective of the date of delivery of such certificate in the case of a certificated Warrant, except that,
if the date of such surrender and payment is a date when the register of members of the Company or book-entry system of the Warrant Agent
are closed, such person shall be deemed to have become the holder of such shares at the close of business on the next succeeding date
on which the share transfer books or book-entry system are open.

 

    7

     

    

 

3.3.5      Maximum
Percentage. A holder of a Warrant may notify the Company in writing in the event it elects to be subject to the provisions contained
in this subsection 3.3.5; however, no holder of a Warrant shall be subject to this subsection 3.3.5 unless he, she
or it makes such election. If the election is made by a holder, the Warrant Agent shall not effect the exercise of the holder’s
Warrant, and such holder shall not have the right to exercise such Warrant, to the extent that after giving effect to such exercise,
such person (together with such person’s affiliates), to the Warrant Agent’s actual knowledge, would beneficially own in
excess of 9.8% (or such other amount as a holder may specify) (the “Maximum Percentage”) of the Ordinary Shares outstanding
immediately after giving effect to such exercise. For purposes of the foregoing sentence, the aggregate number of Ordinary Shares beneficially
owned by such person and its affiliates shall include the number of Ordinary Shares issuable upon exercise of the Warrant with respect
to which the determination of such sentence is being made, but shall exclude Ordinary Shares that would be issuable upon (x) exercise
of the remaining, unexercised portion of the Warrant beneficially owned by such person and its affiliates and (y) exercise or conversion
of the unexercised or unconverted portion of any other securities of the Company beneficially owned by such person and its affiliates
(including, without limitation, any convertible notes or convertible preferred shares or warrants) subject to a limitation on conversion
or exercise analogous to the limitation contained herein. Except as set forth in the preceding sentence, for purposes of this paragraph,
beneficial ownership shall be calculated in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended
(the “Exchange Act”). For purposes of the Warrant, in determining the number of outstanding Ordinary Shares, the holder
may rely on the number of outstanding Ordinary Shares as reflected in (1) the Company’s most recent Annual Report on Form 20-F,
Current Report on Form 6-K or other public filing with the Commission as the case may be, (2) a more recent public announcement
by the Company or (3) any other notice by the Company or Continental Stock Transfer & Trust Company, as transfer agent
(in such capacity, the “Transfer Agent”), setting forth the number of Ordinary Shares outstanding. For any reason
at any time, upon the written request of the holder of the Warrant, the Company shall, within two (2) Business Days, confirm orally
and in writing to such holder the number of Ordinary Shares then outstanding. In any case, the number of issued and outstanding Ordinary
Shares shall be determined after giving effect to the conversion or exercise of equity securities of the Company by the holder and its
affiliates since the date as of which such number of issued and outstanding Ordinary Shares was reported. By written notice to the Company,
the holder of a Warrant may from time to time increase or decrease the Maximum Percentage applicable to such holder to any other percentage
specified in such notice; provided, however, that any such increase shall not be effective until the sixty-first (61st)
day after such notice is delivered to the Company.

 

    8

     

    

 

4.           Adjustments.

 

4.1         Share
Capitalizations.

 

4.1.1      Sub-Divisions.
If after the date hereof, and subject to the provisions of Section 4.6 below, the number of issued and outstanding Ordinary
Shares is increased by a capitalization or share dividend of Ordinary Shares, or by a sub-division of Ordinary Shares or other similar
event, then, on the effective date of such share capitalization, sub-division or similar event, the number of Ordinary Shares issuable
on exercise of each Warrant shall be increased in proportion to such increase in the issued and outstanding Ordinary Shares. A rights
offering made to all or substantially all holders of Ordinary Shares entitling holders to purchase Ordinary Shares at a price less than
the “Historical Fair Market Value” (as defined below) shall be deemed a capitalization of a number of Ordinary Shares equal
to the product of (i) the number of Ordinary Shares actually sold in such rights offering (or issuable under any other equity securities
sold in such rights offering that are convertible into or exercisable for the Ordinary Shares) multiplied by (ii) one (1) minus
the quotient of (x) the price per Ordinary Share paid in such rights offering divided by (y) the Historical Fair Market Value.
For purposes of this subsection 4.1.1, (i) if the rights offering is for securities convertible into or exercisable for Ordinary
Shares, in determining the price payable for Ordinary Shares, there shall be taken into account any consideration received for such rights,
as well as any additional amount payable upon exercise or conversion and (ii) “Historical Fair Market Value”
means the volume weighted average price of the Ordinary Shares during the ten (10) trading day period ending on the trading day
prior to the first date on which the Ordinary Shares trade on the applicable exchange or in the applicable market, regular way, without
the right to receive such rights. No Ordinary Shares shall be issued at less than their par value.

 

4.1.2       Extraordinary
Dividends. If the Company, at any time while the Warrants are outstanding and unexpired, pays to all or substantially all of the holders
of the Ordinary Shares a dividend or makes a distribution in cash, securities or other assets on account of such Ordinary Shares (or other
shares into which the Warrants are convertible), other than (a) as described in subsection 4.1.1 above, or (b) Ordinary
Cash Dividends (as defined below), (any such non-excluded event being referred to herein as an “Extraordinary Dividend”),
then the Warrant Price shall be decreased, effective immediately after the effective date of such Extraordinary Dividend, by the amount
of cash and/or the fair market value (as determined by the Company’s board of directors (the “Board”), in good
faith) of any securities or other assets paid on each Ordinary Share in respect of such Extraordinary Dividend. For purposes of this subsection
4.1.2, “Ordinary Cash Dividends” means any cash dividend or cash distribution which, when combined on a per share
basis with the per share amounts of all other cash dividends and cash distributions paid on the Ordinary Shares during the 365-day period
ending on the date of declaration of such dividend or distribution, does not exceed $0.50 per share (which amount shall be adjusted to
appropriately reflect any of the events referred to in other subsections of this Section 4 and excluding cash dividends or
cash distributions that resulted in an adjustment to the Warrant Price or to the number of Ordinary Shares issuable on exercise of each
Warrant) but only with respect to the amount of the aggregate cash dividends or cash distributions equal to or less than $0.50.

 

4.2         Aggregation
of Shares. If after the date hereof, and subject to the provisions of Section 4.6 hereof, the number of issued and outstanding
Ordinary Shares is decreased by a consolidation, reverse share subdivision or reclassification of Ordinary Shares or other similar event,
then, on the effective date of such consolidation, reverse share subdivision, reclassification or similar event, the number of Ordinary
Shares issuable on exercise of each Warrant shall be decreased in proportion to such decrease in issued and outstanding Ordinary Shares.

 

    9

     

    

 

4.3         Adjustments
in Exercise Price. Whenever the number of Ordinary Shares purchasable upon the exercise of the Warrants is adjusted, as provided
in subsection 4.1.1 or Section 4.2 above, the Warrant Price shall be adjusted (to the nearest cent) by multiplying
such Warrant Price immediately prior to such adjustment by a fraction (x) the numerator of which shall be the number of Ordinary
Shares purchasable upon the exercise of the Warrants immediately prior to such adjustment, and (y) the denominator of which shall
be the number of Ordinary Shares so purchasable immediately thereafter.

 

4.4         [Reserved].

 

4.5         Replacement
of Securities upon Reorganization, etc. In case of any reclassification or reorganization of the issued and outstanding Ordinary
Shares (other than a change under Section 4.1 or Section 4.2 hereof or that solely affects the par value of such
Ordinary Shares), or in the case of any merger or consolidation of the Company with or into another corporation (other than a consolidation
or merger in which the Company is the continuing corporation and that does not result in any reclassification or reorganization of the
issued and outstanding Ordinary Shares), or in the case of any sale or conveyance to another corporation or entity of the assets or other
property of the Company as an entirety or substantially as an entirety in connection with which the Company is dissolved, the holders
of the Warrants shall thereafter have the right to purchase and receive, upon the basis and upon the terms and conditions specified in
the Warrants and in lieu of the Ordinary Shares of the Company immediately theretofore purchasable and receivable upon the exercise of
the rights represented thereby, the kind and amount of shares or stock or other securities or property (including cash) receivable upon
such reclassification, reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer, that the holder
of the Warrants would have received if such holder had exercised his, her or its Warrant(s) immediately prior to such event (the
 “Alternative Issuance”); provided, however, that (i) if the holders of the Ordinary Shares were
entitled to exercise a right of election as to the kind or amount of securities, cash or other assets receivable upon such consolidation
or merger, then the kind and amount of securities, cash or other assets constituting the Alternative Issuance for which each Warrant
shall become exercisable shall be deemed to be the weighted average of the kind and amount received per share by the holders of the Ordinary
Shares in such consolidation or merger that affirmatively make such election, and (ii) if a tender, exchange or redemption offer
shall have been made to and accepted by the holders of the Ordinary Shares under circumstances in which, upon completion of such tender
or exchange offer, the maker thereof, together with members of any group (within the meaning of Rule 13d-5(b)(1) under the
Exchange Act) of which such maker is a part, and together with any affiliate or associate of such maker (within the meaning of Rule 12b-2
under the Exchange Act) and any members of any such group of which any such affiliate or associate is a part, own beneficially (within
the meaning of Rule 13d-3 under the Exchange Act) more than 50% of the issued and outstanding Ordinary Shares, the holder of a Warrant
shall be entitled to receive as the Alternative Issuance, the highest amount of cash, securities or other property to which such holder
would actually have been entitled as a shareholder if such Warrant holder had exercised the Warrant prior to the expiration of such tender
or exchange offer, accepted such offer and all of the Ordinary Shares held by such holder had been purchased pursuant to such tender
or exchange offer, subject to adjustments (from and after the consummation of such tender or exchange offer) as nearly equivalent as
possible to the adjustments provided for in this Section 4; provided further that if less than 70% of the consideration
receivable by the holders of the Ordinary Shares in the applicable event is payable in the form of shares in the successor entity that
is listed for trading on a national securities exchange or is quoted in an established over-the-counter market, or is to be so listed
for trading or quoted immediately following such event, and if the Registered Holder properly exercises the Warrant within thirty (30)
days following the public disclosure of the consummation of such applicable event by the Company pursuant to a Current Report on Form 6-K
filed with the Commission, the Warrant Price shall be reduced by an amount (in dollars) equal to the difference of (i) the Warrant
Price in effect prior to such reduction minus (ii) (A) the Per Share Consideration (as defined below) (but in no event less
than zero) minus (B) the Black-Scholes Warrant Value (as defined below). The “Black-Scholes Warrant Value” means
the value of a Warrant immediately prior to the consummation of the applicable event based on the Black-Scholes Warrant Model for a Capped
American Call on Bloomberg Financial Markets (assuming zero dividends) (“Bloomberg”). For purposes of calculating
such amount, (i) Section 6 of this Agreement shall be taken into account, (ii) the price of each Ordinary Share
shall be the volume weighted average price of the Ordinary Shares during the ten (10) trading day period ending on the trading day
prior to the effective date of the applicable event, (iii) the assumed volatility shall be the 90 day volatility obtained from the
HVT function on Bloomberg determined as of the trading day immediately prior to the day of the announcement of the applicable event and
(iv) the assumed risk-free interest rate shall correspond to the U.S. Treasury rate for a period equal to the remaining term of
the Warrant. “Per Share Consideration” means (i) if the consideration paid to holders of the Ordinary Shares
consists exclusively of cash, the amount of such cash per Ordinary Share, and (ii) in all other cases, the volume weighted average
price of the Ordinary Shares during the ten (10) trading day period ending on the trading day prior to the effective date of the
applicable event. If any reclassification or reorganization also results in a change in Ordinary Shares covered by subsection 4.1.1,
then such adjustment shall be made pursuant to subsection 4.1.1 or Sections 4.2, 4.3 and this Section 4.5.
The provisions of this Section 4.5 shall similarly apply to successive reclassifications, reorganizations, mergers or consolidations,
sales or other transfers. In no event shall the Warrant Price be reduced to less than the par value per share issuable upon exercise
of such Warrant.

 

    10

     

    

 

4.6         Notices
of Changes in Warrant. Upon every adjustment of the Warrant Price or the number of Ordinary Shares issuable upon exercise of a Warrant,
the Company shall give written notice thereof to the Warrant Agent, which notice shall state the Warrant Price resulting from such adjustment
and the increase or decrease, if any, in the number of Ordinary Shares purchasable at such price upon the exercise of a Warrant, setting
forth in reasonable detail the method of calculation and the facts upon which such calculation is based. Upon the occurrence of any event
specified in Sections 4.1, 4.2, 4.3 or 4.5, the Company shall give written notice of the occurrence of such
event to each holder of a Warrant, at the last address set forth for such holder in the Warrant Register, of the record date or the effective
date of the event. Failure to give such notice, or any defect therein, shall not affect the legality or validity of such event.

 

    11

     

    

 

4.7         No
Fractional Shares. Notwithstanding any provision contained in this Agreement to the contrary, the Company shall not issue fractional
shares upon the exercise of Warrants. If, by reason of any adjustment made pursuant to this Section 4, the holder of any Warrant
would be entitled, upon the exercise of such Warrant, to receive a fractional interest in a share, the Company shall, upon such exercise,
round down to the nearest whole number the number of Ordinary Shares to be issued to such holder.

 

4.8         Form of
Warrant. The form of Warrant need not be changed because of any adjustment pursuant to this Section 4, and Warrants issued
after such adjustment may state the same Warrant Price and the same number of Ordinary Shares as is stated in the Warrants initially issued
pursuant to this Agreement; provided, however, that the Company may at any time in its sole discretion make any change in
the form of Warrant that the Company may deem appropriate and that does not affect the substance thereof, and any Warrant thereafter issued
or countersigned, whether in exchange or substitution for an outstanding Warrant or otherwise, may be in the form as so changed.

 

5.           Transfer
and Exchange of Warrants.

 

5.1         Registration
of Transfer. The Warrant Agent shall register the transfer, from time to time, of any outstanding Warrant upon the Warrant Register,
upon surrender of such Warrant for transfer, in the case of certificated Warrants, properly endorsed with signatures properly guaranteed
and accompanied by appropriate instructions for transfer. Upon any such transfer, a new Warrant representing an equal aggregate number
of Warrants shall be issued and the old Warrant shall be cancelled by the Warrant Agent. In the case of certificated Warrants, the Warrants
so cancelled shall be delivered by the Warrant Agent to the Company from time to time upon request.

 

5.2         Procedure
for Surrender of Warrants. Warrants may be surrendered to the Warrant Agent, together with a written request for exchange or transfer,
and thereupon the Warrant Agent shall issue in exchange therefor one or more new Warrants as requested by the Registered Holder of the
Warrants so surrendered, representing an equal aggregate number of Warrants; provided, however, that except as otherwise
provided herein or with respect to any Book-Entry Warrant, each Book-Entry Warrant may be transferred only in whole and only to the Depositary,
to another nominee of the Depositary, to a successor depository, or to a nominee of a successor depository; provided further,
however that in the event that a Warrant surrendered for transfer bears a restrictive legend (as in the case of the Private Placement
Warrants), the Warrant Agent shall not cancel such Warrant and issue new Warrants in exchange thereof until the Warrant Agent has received
an opinion of counsel for the Company stating that such transfer may be made and indicating whether the new Warrants must also bear a
restrictive legend.

 

5.3         Fractional
Warrants. The Warrant Agent shall not be required to effect any registration of transfer or exchange which shall result in the issuance
of a warrant certificate or book-entry position for a fraction of a Warrant.

 

5.4         Service
Charges. No service charge shall be made for any exchange or registration of transfer of Warrants.

 

    12

     

    

 

5.5        Warrant
Execution and Countersignature. The Warrant Agent is hereby authorized to countersign and to deliver, in accordance with the terms
of this Agreement, the Warrants required to be issued pursuant to the provisions of this Section 5, and the Company, whenever
required by the Warrant Agent, shall supply the Warrant Agent with Warrants duly executed on behalf of the Company for such purpose.

 

6.            Redemption.

 

6.1         Redemption
of Warrants for Cash. Subject to Section 6.5 hereof, not less than all of the outstanding Warrants may be redeemed, at
the option of the Company, at any time during the Exercise Period, at the office of the Warrant Agent, upon notice to the Registered
Holders of the Warrants, as described in Section 6.3 below, at a Redemption Price of $0.01 per Warrant, provided that
(a) the Reference Value equals or exceeds $18.00 per share (subject to adjustment in compliance with Section 4 hereof)
and (b) there is an effective registration statement covering the issuance of the Ordinary Shares issuable upon exercise of the
Warrants, and a current prospectus relating thereto, available throughout the 30-day Redemption Period (as defined in Section 6.3
below).

 

6.2         Redemption
of Warrants for Ordinary Shares. Subject to Section 6.5 hereof, not less than all of the outstanding Warrants may be redeemed,
at the option of the Company, at any time during the Exercise Period, at the office of the Warrant Agent, upon notice to the Registered
Holders of the Warrants, as described in Section 6.3 below, at a Redemption Price of $0.10 per Warrant, provided that
(i) the Reference Value equals or exceeds $10.00 per share (subject to adjustment in compliance with Section 4 hereof)
and (ii) if the Reference Value is less than $18.00 per share (subject to adjustment in compliance with Section 4 hereof),
the Private Placement Warrants are also concurrently called for redemption on the same terms as the outstanding Public Warrants. During
the 30-day Redemption Period in connection with a redemption pursuant to this Section 6.2, Registered Holders of the Warrants
may elect to exercise their Warrants on a “cashless basis” pursuant to subsection 3.3.1 and receive a number of Ordinary
Shares determined by reference to the table below, based on the Redemption Date (calculated for purposes of the table as the period to
expiration of the Warrants) and the “Redemption Fair Market Value” (as such term is defined in this Section 6.2)
(a “Make-Whole Exercise”). Solely for purposes of this Section 6.2, the “Redemption Fair Market
Value” shall mean the volume weighted average price of the Ordinary Shares for the ten (10) trading days immediately following
the date on which notice of redemption pursuant to this Section 6.2 is sent to the Registered Holders. In connection with
any redemption pursuant to this Section 6.2, the Company shall provide the Registered Holders with the Redemption Fair Market
Value no later than one (1) Business Day after the ten (10) trading day period described above ends.

 

    13

     

    

 

	 	 	Redemption Fair Market Value of Ordinary Shares 

(period to expiration of warrants)	 
	Redemption Date	 	£ 10.00	 	11.00	 	12.00	 	13.00	 	14.00	 	15.00	 	16.00	 	17.00	 	3 18.00	 
	60 months	 	0.261	 	0.281	 	0.297	 	0.311	 	0.324	 	0.337	 	0.348	 	0.358	 	0.361	 
	57 months	 	0.257	 	0.277	 	0.294	 	0.310	 	0.324	 	0.337	 	0.348	 	0.358	 	0.361	 
	54 months	 	0.252	 	0.272	 	0.291	 	0.307	 	0.322	 	0.335	 	0.347	 	0.357	 	0.361	 
	51 months	 	0.246	 	0.268	 	0.287	 	0.304	 	0.320	 	0.333	 	0.346	 	0.357	 	0.361	 
	48 months	 	0.241	 	0.263	 	0.283	 	0.301	 	0.317	 	0.332	 	0.344	 	0.356	 	0.361	 
	45 months	 	0.235	 	0.258	 	0.279	 	0.298	 	0.315	 	0.330	 	0.343	 	0.356	 	0.361	 
	42 months	 	0.228	 	0.252	 	0.274	 	0.294	 	0.312	 	0.328	 	0.342	 	0.355	 	0.361	 
	39 months	 	0.221	 	0.246	 	0.269	 	0.290	 	0.309	 	0.325	 	0.340	 	0.354	 	0.361	 
	36 months	 	0.213	 	0.239	 	0.263	 	0.285	 	0.305	 	0.323	 	0.339	 	0.353	 	0.361	 
	33 months	 	0.205	 	0.232	 	0.257	 	0.280	 	0.301	 	0.320	 	0.337	 	0.352	 	0.361	 
	30 months	 	0.196	 	0.224	 	0.250	 	0.274	 	0.297	 	0.316	 	0.335	 	0.351	 	0.361	 
	27 months	 	0.185	 	0.214	 	0.242	 	0.268	 	0.291	 	0.313	 	0.332	 	0.350	 	0.361	 
	24 months	 	0.173	 	0.204	 	0.233	 	0.260	 	0.285	 	0.308	 	0.329	 	0.348	 	0.361	 
	21 months	 	0.161	 	0.193	 	0.223	 	0.252	 	0.279	 	0.304	 	0.326	 	0.347	 	0.361	 
	18 months	 	0.146	 	0.179	 	0.211	 	0.242	 	0.271	 	0.298	 	0.322	 	0.345	 	0.361	 
	15 months	 	0.130	 	0.164	 	0.197	 	0.230	 	0.262	 	0.291	 	0.317	 	0.342	 	0.361	 
	12 months	 	0.111	 	0.146	 	0.181	 	0.216	 	0.250	 	0.282	 	0.312	 	0.339	 	0.361	 
	9 months	 	0.090	 	0.125	 	0.162	 	0.199	 	0.237	 	0.272	 	0.305	 	0.336	 	0.361	 
	6 months	 	0.065	 	0.099	 	0.137	 	0.178	 	0.219	 	0.259	 	0.296	 	0.331	 	0.361	 
	3 months	 	0.034	 	0.065	 	0.104	 	0.150	 	0.197	 	0.243	 	0.286	 	0.326	 	0.361	 
	0 months	 	—	 	—	 	0.042	 	0.115	 	0.179	 	0.233	 	0.281	 	0.323	 	0.361	 

 

The exact Redemption Fair
Market Value and Redemption Date may not be set forth in the table above, in which case, if the Redemption Fair Market Value is between
two values in the table or the Redemption Date is between two redemption dates in the table, the number of Ordinary Shares to be issued
for each Warrant exercised in a Make-Whole Exercise shall be determined by a straight-line interpolation between the number of shares
set forth for the higher and lower Redemption Fair Market Values and the earlier and later redemption dates, as applicable, based on a
365- or 366-day year, as applicable.

 

The share prices set forth
in the column headings of the table above shall be adjusted as of any date on which the number of Ordinary Shares issuable upon exercise
of a Warrant or the Exercise Price is adjusted pursuant to Section 4 hereof. If the number of Ordinary Shares issuable upon
exercise of a Warrant is adjusted pursuant to Section 4 hereof, the adjusted share prices in the column headings shall equal
the share prices immediately prior to such adjustment, multiplied by a fraction, the numerator of which is the number of shares deliverable
upon exercise of a Warrant immediately prior to such adjustment and the denominator of which is the number of shares deliverable upon
exercise of a Warrant as so adjusted. The number of shares in the table above shall be adjusted in the same manner and at the same time
as the number of shares issuable upon exercise of a Warrant. If the Exercise Price of a Warrant is adjusted pursuant to Section 4.1.2
hereof, the adjusted share prices in the column headings shall equal the share prices immediately prior to such adjustment less the decrease
in the Exercise Price pursuant to such Exercise Price adjustment. In no event shall the number of shares issued in connection with a Make-Whole
Exercise exceed 0.361 Ordinary Shares per Warrant (subject to adjustment).

 

6.3         Date
Fixed for, and Notice of, Redemption; Redemption Price; Reference Value. In the event that the Company elects to redeem the Warrants
pursuant to Sections 6.1 or 6.2, the Company shall fix a date for the redemption (the “Redemption Date”). Notice
of redemption shall be mailed by first class mail, postage prepaid, by the Company not less than thirty (30) days prior to the Redemption
Date (the “30-day Redemption Period”) to the Registered Holders of the Warrants to be redeemed at their last addresses
as they shall appear on the registration books. Any notice mailed in the manner herein provided shall be conclusively presumed to have
been duly given whether or not the Registered Holder received such notice. As used in this Agreement, (a) “Redemption Price”
shall mean the price per Warrant at which any Warrants are redeemed pursuant to Sections 6.1 or 6.2 and (b) “Reference
Value” shall mean the last reported sales price of the Ordinary Shares for any twenty (20) trading days within the thirty (30)
trading-day period ending on the third trading day prior to the date on which notice of the redemption is given.

 

    14

     

    

 

6.4         Exercise
After Notice of Redemption. The Warrants may be exercised, for cash (or on a “cashless basis” in accordance with Section 6.2
of this Agreement) at any time after notice of redemption shall have been given by the Company pursuant to Section 6.3
hereof and prior to the Redemption Date. On and after the Redemption Date, the record holder of the Warrants shall have no further rights
except to receive, upon surrender of the Warrants, the Redemption Price.

 

6.5         Exclusion
of Private Placement Warrants. The Company agrees that (a) the redemption rights provided in Section 6.1 hereof shall
not apply to the Private Placement Warrants if at the time of the redemption such Private Placement Warrants continue to be held by the
Sponsor or its Permitted Transferees and (b) if the Reference Value equals or exceeds $18.00 per share (subject to adjustment in
compliance with Section 4 hereof), the redemption rights provided in Section 6.2 hereof shall not apply to the
Private Placement Warrants if at the time of the redemption such Private Placement Warrants continue to be held by the Sponsor or its
Permitted Transferees. However, once such Private Placement Warrants are transferred (other than to Permitted Transferees in accordance
with Section 2.5 hereof), the Company may redeem the Private Placement Warrants pursuant to Section 6.1 or 6.2
hereof, provided that the criteria for redemption are met, including the opportunity of the holder of such Private Placement Warrants
to exercise the Private Placement Warrants prior to redemption pursuant to Section 6.4 hereof. Private Placement Warrants
that are transferred to persons other than Permitted Transferees shall upon such transfer cease to be Private Placement Warrants and shall
become Public Warrants under this Agreement, including for purposes of Section 9.8 hereof.

 

7.           Other
Provisions Relating to Rights of Holders of Warrants.

 

7.1         No
Rights as Shareholder. A Warrant does not entitle the Registered Holder thereof to any of the rights of a shareholder of the Company,
including, without limitation, the right to receive dividends, or other distributions, to exercise any preemptive rights to vote or to
consent or to receive notice as shareholders in respect of the meetings of shareholders or the election of directors of the Company or
any other matter.

 

7.2         Lost,
Stolen, Mutilated, or Destroyed Warrants. If any Warrant is lost, stolen, mutilated, or destroyed, the Company and the Warrant Agent
may on such terms as to indemnity or otherwise as they may in their discretion impose (which shall, in the case of a mutilated Warrant,
include the surrender thereof), issue a new Warrant of like denomination, tenor, and date as the Warrant so lost, stolen, mutilated, or
destroyed. Any such new Warrant shall constitute a substitute contractual obligation of the Company, whether or not the allegedly lost,
stolen, mutilated, or destroyed Warrant shall be at any time enforceable by anyone.

 

    15

     

    

 

 

7.3            Reservation
of Ordinary Shares. The Company shall at all times reserve and keep available a number of its authorized but unissued Ordinary Shares
that shall be sufficient to permit the exercise in full of all outstanding Warrants issued pursuant to this Agreement.

 

7.4            Registration
of Ordinary Shares; Cashless Exercise at Company’s Option.

 

7.4.1            Registration
of the Ordinary Shares. The Company agrees that as soon as practicable, but in no event later than twenty (20) Business Days after
the Effective Date, it shall use its commercially reasonable efforts to file with the Commission a registration statement for the registration,
under the Securities Act, of the Ordinary Shares issuable upon exercise of the Warrants. The Company shall use its commercially reasonable
efforts to cause the same to become effective within sixty (60) Business Days following the Effective Date and to maintain the effectiveness
of such registration statement, and a current prospectus relating thereto, until the expiration or redemption of the Warrants in accordance
with the provisions of this Agreement. If any such registration statement has not been declared effective by the sixtieth (60th)
Business Day following the Effective Date, holders of the Warrants shall have the right, during the period beginning on the sixty-first
(61st) Business Day after the Effective Date and ending upon such registration statement being declared effective by the Commission,
and during any other period when the Company shall fail to have maintained an effective registration statement covering the issuance of
the Ordinary Shares issuable upon exercise of the Warrants, to exercise such Warrants on a “cashless basis,” by exchanging
the Warrants (in accordance with Section 3(a)(9) of the Securities Act or another exemption) for that number of Ordinary Shares
equal to the lesser of (A) the quotient obtained by dividing (x) the product of the number of Ordinary Shares underlying the
Warrants, multiplied by the excess of the “Fair Market Value” (as defined below) over the Warrant Price by (y) the Fair
Market Value and (B) 0.361. Solely for purposes of this subsection 7.4.1, “Fair Market Value” shall mean
the volume-weighted average price of the Ordinary Shares as reported during the ten (10) trading day period ending on the trading
day prior to the date that notice of exercise is received by the Warrant Agent from the holder of such Warrants or its securities broker
or intermediary. The date that notice of “cashless exercise” is received by the Warrant Agent shall be conclusively determined
by the Warrant Agent. In connection with the “cashless exercise” of a Public Warrant, the Company shall, upon request, provide
the Warrant Agent with an opinion of counsel for the Company (which shall be an outside law firm with securities law experience) stating
that (i) the exercise of the Warrants on a “cashless basis” in accordance with this subsection 7.4.1 is not required
to be registered under the Securities Act and (ii) the Ordinary Shares issued upon such exercise shall be freely tradable under United
States federal securities laws by anyone who is not an affiliate (as such term is defined in Rule 144 under the Securities Act) of
the Company and, accordingly, shall not be required to bear a restrictive legend. Except as provided in subsection 7.4.2, for the
avoidance of doubt, unless and until all of the Warrants have been exercised or have expired, the Company shall continue to be obligated
to comply with its registration obligations under the first three sentences of this subsection 7.4.1.

 

    16

     

    

 

7.4.2            Cashless
Exercise at Company’s Option. If the Ordinary Shares are at the time of any exercise of a Public Warrant not listed on a national
securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the
Securities Act, the Company may, at its option, (i) require holders of Public Warrants who exercise Public Warrants to exercise such
Public Warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act as described in subsection
7.4.1 and (ii) in the event the Company so elects, the Company shall (x) not be required to file or maintain in effect a
registration statement for the registration, under the Securities Act, of the Ordinary Shares issuable upon exercise of the Warrants,
notwithstanding anything in this Agreement to the contrary, and (y) use its commercially reasonable efforts to register or qualify
for sale the Ordinary Shares issuable upon exercise of the Public Warrant under applicable blue sky laws to the extent an exemption is
not available.

 

8.            Concerning
the Warrant Agent and Other Matters.

 

8.1            Payment
of Taxes. The Company shall from time to time promptly pay all taxes and charges that may be imposed upon the Company or the Warrant
Agent in respect of the issuance or delivery of Ordinary Shares upon the exercise of the Warrants, but the Company shall not be obligated
to pay any transfer taxes in respect of the Warrants or such shares.

 

8.2            Resignation,
Consolidation, or Merger of Warrant Agent.

 

8.2.1            Appointment
of Successor Warrant Agent. The Warrant Agent, or any successor to it hereafter appointed, may resign its duties and be discharged
from all further duties and liabilities hereunder after giving sixty (60) days’ notice in writing to the Company. If the office
of the Warrant Agent becomes vacant by resignation or incapacity to act or otherwise, the Company shall appoint in writing a successor
Warrant Agent in place of the Warrant Agent. If the Company shall fail to make such appointment within a period of thirty (30) days after
it has been notified in writing of such resignation or incapacity by the Warrant Agent or by the holder of a Warrant (who shall, with
such notice, submit his, her or its Warrant for inspection by the Company), then the holder of any Warrant may apply to the Supreme Court
of the State of New York for the County of New York for the appointment of a successor Warrant Agent at the Company’s cost. Any
successor Warrant Agent, whether appointed by the Company or by such court, shall be a corporation or other entity organized and existing
under the laws of the State of New York, in good standing and having its principal office in the United States of America, and authorized
under such laws to exercise corporate trust powers and subject to supervision or examination by federal or state authority. After appointment,
any successor Warrant Agent shall be vested with all the authority, powers, rights, immunities, duties, and obligations of its predecessor
Warrant Agent with like effect as if originally named as Warrant Agent hereunder, without any further act or deed; but if for any reason
it becomes necessary or appropriate, the predecessor Warrant Agent shall execute and deliver, at the expense of the Company, an instrument
transferring to such successor Warrant Agent all the authority, powers, and rights of such predecessor Warrant Agent hereunder; and upon
request of any successor Warrant Agent the Company shall make, execute, acknowledge, and deliver any and all instruments in writing for
more fully and effectually vesting in and confirming to such successor Warrant Agent all such authority, powers, rights, immunities, duties,
and obligations.

 

    17

     

    

 

8.2.2            Notice
of Successor Warrant Agent. In the event a successor Warrant Agent shall be appointed, the Company shall give notice thereof to the
predecessor Warrant Agent and the Transfer Agent for the Ordinary Shares not later than the effective date of any such appointment.

 

8.2.3            Merger
or Consolidation of Warrant Agent. Any entity into which the Warrant Agent may be merged or with which it may be consolidated or any
entity resulting from any merger or consolidation to which the Warrant Agent shall be a party shall be the successor Warrant Agent under
this Agreement without any further act.

 

8.3            Fees
and Expenses of Warrant Agent.

 

8.3.1            Remuneration.
The Company agrees to pay the Warrant Agent reasonable remuneration for its services as such Warrant Agent hereunder and shall, pursuant
to its obligations under this Agreement, reimburse the Warrant Agent upon demand for all expenditures that the Warrant Agent may reasonably
incur in the execution of its duties hereunder.

 

8.3.2            Further
Assurances. The Company agrees to perform, execute, acknowledge, and deliver or cause to be performed, executed, acknowledged, and
delivered all such further and other acts, instruments, and assurances as may reasonably be required by the Warrant Agent for the carrying
out or performing of the provisions of this Agreement.

 

8.4            Liability
of Warrant Agent.

 

8.4.1            Reliance
on Company Statement. Whenever in the performance of its duties under this Agreement, the Warrant Agent shall deem it necessary or
desirable that any fact or matter be proved or established by the Company prior to taking or suffering any action hereunder, such fact
or matter (unless other evidence in respect thereof be herein specifically prescribed) may be deemed to be conclusively proved and established
by a statement signed by the Chairman of the Board, Chairman, Co-Chairman, Chief Executive Officer or the President of the Company and
delivered to the Warrant Agent. The Warrant Agent may rely upon such statement for any action taken or suffered in good faith by it pursuant
to the provisions of this Agreement.

 

8.4.2            Indemnity.
The Warrant Agent shall be liable hereunder only for its own gross negligence, willful misconduct, fraud or bad faith. The Company agrees
to indemnify the Warrant Agent and save it harmless against any and all liabilities, including judgments, out-of-pocket costs and reasonable
outside counsel fees, for anything done or omitted by the Warrant Agent in the execution of this Agreement, except as a result of the
Warrant Agent’s gross negligence, willful misconduct, fraud or bad faith.

 

8.4.3            Exclusions.
The Warrant Agent shall have no responsibility with respect to the validity of this Agreement or with respect to the validity or execution
of any Warrant (except its countersignature thereof). The Warrant Agent shall not be responsible for any breach by the Company of any
covenant or condition contained in this Agreement or in any Warrant. The Warrant Agent shall not be responsible to make any adjustments
required under the provisions of Section 4 hereof or responsible for the manner, method, or amount of any such adjustment
or the ascertaining of the existence of facts that would require any such adjustment; nor shall it by any act hereunder be deemed to make
any representation or warranty as to the authorization or reservation of any Ordinary Shares to be issued pursuant to this Agreement or
any Warrant or as to whether any Ordinary Shares shall, when issued, be valid and fully paid and non-assessable.

 

    18

     

    

 

8.5            Acceptance
of Agency. The Warrant Agent hereby accepts the agency established by this Agreement and agrees to perform the same upon the terms
and conditions herein set forth and among other things, shall account promptly to the Company with respect to Warrants exercised and concurrently
account for, and pay to the Company, all monies received by the Warrant Agent for the purchase of Ordinary Shares through the exercise
of the Warrants.

 

8.6            Waiver.
The Warrant Agent has no right of set-off or any other right, title, interest or claim of any kind (“Claim”) in, or
to any distribution of, the Trust Account (as defined in that certain Investment Management Trust Agreement, dated as of January 5,
2021, by and between SPAC and Continental Stock Transfer & Trust Company as trustee thereunder) and hereby agrees not to seek
recourse, reimbursement, payment or satisfaction for any Claim against the Trust Account for any reason whatsoever. The Warrant Agent
hereby waives any and all Claims against the Trust Account and any and all rights to seek access to the Trust Account.

 

9.            Miscellaneous
Provisions.

 

9.1            Successors.
All the covenants and provisions of this Agreement by or for the benefit of the Company or the Warrant Agent shall bind and inure to the
benefit of their respective successors and assigns.

 

    19

     

    

 

9.2            Notices.
Any notice, statement or demand authorized by this Agreement to be given or made by the Warrant Agent or by the holder of any Warrant
to or on the Company shall be sufficiently given when so delivered if by hand or overnight delivery or if sent by certified mail or private
courier service within five (5) days after deposit of such notice, postage prepaid, addressed (until another address is filed in
writing by the Company with the Warrant Agent), as follows:

 

Gogoro Inc.

11F, Building C,

No. 225, Section 2, Chang’an E. Rd.,

SongShan District, Taipei City 105

Taiwan

Attn: Hok-Sum Horace Luke; Bruce
Morrison Aitken; Titan Lee

E mail: horace.luke@gogoro.com; bruce.aitken@gogoro.com;

titan.lee@gogoro,com

 

with a copy (which shall not constitute notice) to:

 

Wilson Sonsini Goodrich & Rosati, P.C.

650 Page Mill Road

Palo Alto, CA 94304

Attn: Mark Baudler

E mail: MBaudler@wsgr.com

 

Wilson Sonsini Goodrich & Rosati, P.C.

One Market Plaza

Spear Tower, Suite 3300

San Francisco, CA 94304

Attn: Robert Ishii

E mail: RIshii@wsgr.com

 

Any notice, statement or demand
authorized by this Agreement to be given or made by the holder of any Warrant or by the Company to or on the Warrant Agent shall be sufficiently
given when so delivered if by hand or overnight delivery or if sent by certified mail or private courier service within five (5) days
after deposit of such notice, postage prepaid, addressed (until another address is filed in writing by the Warrant Agent with the Company),
as follows:

 

Continental Stock Transfer & Trust Company

One State Street, 30th Floor

New York, NY 10004

Attention: Compliance Department

 

9.3            Applicable
Law and Exclusive Forum. The validity, interpretation, and performance of this Agreement and of the Warrants shall be governed in
all respects by the laws of the State of New York. Subject to applicable law, the Company hereby agrees that any action, proceeding or
claim against it arising out of or relating in any way to this Agreement shall be brought and enforced in the courts of the State of New
York or the United States District Court for the Southern District of New York, and irrevocably submits to such jurisdiction, which jurisdiction
shall be exclusive forum for any such action, proceeding or claim. The Company hereby waives any objection to such exclusive jurisdiction
and that such courts represent an inconvenient forum. Notwithstanding the foregoing, the provisions of this paragraph will not apply to
suits brought to enforce any liability or duty created by the Exchange Act or any other claim for which the federal district courts of
the United States of America are the sole and exclusive forum.

 

    20

     

    

 

Any person or entity purchasing
or otherwise acquiring any interest in the Warrants shall be deemed to have notice of and to have consented to the forum provisions in
this Section 9.3. If any action, the subject matter of which is within the scope of the forum provisions above, is filed in
a court other than a court located within the State of New York or the United States District Court for the Southern District of New York
(a “foreign action”) in the name of any warrant holder, such warrant holder shall be deemed to have consented to: (x) the
personal jurisdiction of the state and federal courts located within the State of New York or the United States District Court for the
Southern District of New York in connection with any action brought in any such court to enforce the forum provisions (an “enforcement
action”), and (y) having service of process made upon such warrant holder in any such enforcement action by service upon
such warrant holder’s counsel in the foreign action as agent for such warrant holder.

 

9.4            Persons
Having Rights under this Agreement. Nothing in this Agreement shall be construed to confer upon, or give to, any person, corporation
or other entity other than the parties hereto and the Registered Holders of the Warrants any right, remedy, or claim under or by reason
of this Agreement or of any covenant, condition, stipulation, promise, or agreement hereof. All covenants, conditions, stipulations, promises,
and agreements contained in this Agreement shall be for the sole and exclusive benefit of the parties hereto and their successors and
assigns and of the Registered Holders of the Warrants.

 

9.5            Examination
of the Warrant Agreement. A copy of this Agreement shall be available at all reasonable times at the office of the Warrant Agent in
the United States of America, for inspection by the Registered Holder of any Warrant. The Warrant Agent may require any such holder to
submit such holder’s Warrant for inspection by the Warrant Agent.

 

9.6            Counterparts.
This Agreement may be executed in any number of original or facsimile counterparts and each of such counterparts shall for all purposes
be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument.

 

9.7            Effect
of Headings. The section headings herein are for convenience only and are not part of this Agreement and shall not affect the interpretation
thereof.

 

    21

     

    

 

9.8            Amendments.
This Agreement may be amended by the parties hereto without the consent of any Registered Holder for the purpose of (i) curing any
ambiguity or correcting any mistake, including to conform the provisions hereof to the description of the terms of the Warrants and this
Agreement set forth in the Prospectus, or defective provision contained herein, (ii) amending the definition of “Ordinary Cash
Dividend” as contemplated by and in accordance with the second sentence of subsection 4.1.2 or (iii) adding or changing
any provisions with respect to matters or questions arising under this Agreement as the parties may deem necessary or desirable and that
the parties deem shall not adversely affect the rights of the Registered Holders under this Agreement. All other modifications or amendments,
including any modification or amendment to increase the Warrant Price or shorten the Exercise Period and any amendment to the terms of
only the Private Placement Warrants, shall require the vote or written consent of the Registered Holders of 50% of the then-outstanding
Public Warrants and, solely with respect to any amendment to the terms of the Private Placement Warrants or any provision of this Agreement
with respect to the Private Placement Warrants, 50% of the then-outstanding Private Placement Warrants. Notwithstanding the foregoing,
the Company may lower the Warrant Price or extend the duration of the Exercise Period pursuant to Sections 3.1 and 3.2, respectively,
without the consent of the Registered Holders.

 

9.9            Severability.
This Agreement shall be deemed severable, and the invalidity or unenforceability of any term or provision hereof shall not affect the
validity or enforceability of this Agreement or of any other term or provision hereof. Furthermore, in lieu of any such invalid or unenforceable
term or provision, the parties hereto intend that there shall be added as a part of this Agreement a provision as similar in terms to
such invalid or unenforceable provision as may be possible and be valid and enforceable.

 

[Signature Page Follows]

 

    22

     

    

 

IN WITNESS WHEREOF, the parties
hereto have caused this Agreement to be duly executed as of the date first above written.

 

	 	GOGORO INC.
	 	 
	 	By:	         
	 	Name:
	 	Title:

 

[Signature Page to
Assignment and Assumption Agreement]

 

    

     

    

 

IN WITNESS WHEREOF, the parties
hereto have caused this Agreement to be duly executed as of the date first above written.

 

	 	POEMA GLOBAL HOLDINGS CORP.
	 	 
	 	By:	              
	 	Name: Joaquin Rodriguez Torres
	 	Title: Co-Chairman
	 	 
	 	By:	 
	 	Name: Homer Sun
	 	Title: CEO

 

[Signature Page to
Assignment and Assumption Agreement]

 

    

     

    

 

IN WITNESS WHEREOF, the parties
hereto have caused this Agreement to be duly executed as of the date first above written.

 

	 	CONTINENTAL STOCK TRANSFER &
    TRUST COMPANY,
	 	as Warrant Agent
	 	 
	 	By:	                
	 	Name:
	 	Title:

 

[Signature Page to
Assignment and Assumption Agreement]

 

    

     

    

 

EXHIBIT A

Form of Warrant Certificate

[FACE]

Number

Warrants

THIS WARRANT SHALL BE VOID IF NOT EXERCISED
PRIOR TO

THE EXPIRATION OF THE EXERCISE PERIOD PROVIDED FOR

IN THE WARRANT AGREEMENT DESCRIBED BELOW

 

Gogoro Inc.

 

Incorporated Under the Laws of the Cayman Islands

 

CUSIP
[·]

 

Warrant Certificate

 

This
Warrant Certificate certifies that [·], or registered assigns, is the registered holder of [·] warrant(s) (the “Warrants”
and each, a “Warrant”) to purchase ordinary shares, [·] par
value per share (the “Ordinary Shares”), of Gogoro Inc., an exempted company incorporated with limited liability
under the Laws of Cayman Islands (the “Company”). Each Warrant entitles the holder, upon exercise during the
period set forth in the Warrant Agreement referred to below, to receive from the Company that number of fully paid and non-assessable
Ordinary Shares as set forth below, at the exercise price (the “Exercise Price”) as determined pursuant to the
Warrant Agreement, payable in lawful money (or through “cashless exercise” as provided for in the Warrant Agreement)
of the United States of America upon surrender of this Warrant Certificate and payment of the Exercise Price at the office or agency of
the Warrant Agent referred to below, subject to the conditions set forth herein and in the Warrant Agreement. Defined terms used in this
Warrant Certificate but not defined herein shall have the meanings given to them in the Warrant Agreement.

 

Each whole Warrant is initially
exercisable for one fully paid and non-assessable Ordinary Share. Fractional shares shall not be issued upon exercise of any Warrant.
If, upon the exercise of Warrants, a holder would be entitled to receive a fractional interest in an Ordinary Share, the Company shall,
upon exercise, round down to the nearest whole number the number of Ordinary Shares to be issued to the Warrant holder. The number of
Ordinary Shares issuable upon exercise of the Warrants is subject to adjustment upon the occurrence of certain events as set forth in
the Warrant Agreement.

 

The initial Exercise Price
per one Ordinary Share for any Warrant is equal to $11.50 per share. The Exercise Price is subject to adjustment upon the occurrence of
certain events as set forth in the Warrant Agreement.

 

Subject to the conditions
set forth in the Warrant Agreement, the Warrants may be exercised only during the Exercise Period and to the extent not exercised by the
end of such Exercise Period, such Warrants shall become void. The Warrants may be redeemed, subject to certain conditions as set forth
in the Warrant Agreement.

 

    A-1

     

    

 

Reference is hereby made to
the further provisions of this Warrant Certificate set forth on the reverse hereof and such further provisions shall for all purposes
have the same effect as though fully set forth at this place.

 

This Warrant Certificate shall
not be valid unless countersigned by the Warrant Agent, as such term is used in the Warrant Agreement. This Warrant Certificate shall
be governed by and construed in accordance with the internal laws of the State of New York.

 

	 	GOGORO INC.
	 	 
	 	By:	                        
	 	Name:
	 	Title:
	 	 
	 	CONTINENTAL STOCK TRANSFER &
    TRUST COMPANY,
	 	as Warrant Agent
	 	 
	 	By:	 
	 	Name:
	 	Title:

 

    A-2

     

    

 

[Form of Warrant Certificate]

[Reverse]

 

The
Warrants evidenced by this Warrant Certificate are part of a duly authorized issue of Warrants entitling the holder on exercise to receive
[●] Ordinary Shares and are issued or to be issued pursuant to an Assignment, Assumption and Amended and Restated Warrant Agreement, dated
as of [·], 202[●] (as amended from time to time, the “Warrant
Agreement”), duly executed and delivered by the Company to Continental Stock Transfer & Trust Company, a New York
limited purpose trust company, as warrant agent (the “Warrant Agent”), which Warrant Agreement is hereby incorporated
by reference in and made a part of this instrument and is hereby referred to for a description of the rights, limitation of rights, obligations,
duties and immunities thereunder of the Warrant Agent, the Company and the holders (the words “holders” or “holder”
meaning the Registered Holders or Registered Holder, respectively) of the Warrants. A copy of the Warrant Agreement may be obtained by
the holder hereof upon written request to the Company. Defined terms used in this Warrant Certificate but not defined herein shall have
the meanings given to them in the Warrant Agreement.

 

Warrants may be exercised
at any time during the Exercise Period set forth in the Warrant Agreement. The holder of Warrants evidenced by this Warrant Certificate
may exercise them by surrendering this Warrant Certificate, with the form of Election to Purchase set forth hereon properly completed
and executed, together with payment of the Exercise Price as specified in the Warrant Agreement (or through “cashless exercise”
as provided for in the Warrant Agreement) at the principal corporate trust office of the Warrant Agent. In the event that upon any exercise
of Warrants evidenced hereby the number of Warrants exercised shall be less than the total number of Warrants evidenced hereby, there
shall be issued to the holder hereof, or his, her or its assignee, a new Warrant Certificate evidencing the number of Warrants not exercised.

 

Notwithstanding anything else
in this Warrant Certificate or the Warrant Agreement, no Warrant may be exercised unless at the time of exercise (i) a registration
statement covering the issuance of the Ordinary Shares to be issued upon exercise is effective under the Securities Act and (ii) a
prospectus thereunder relating to the Ordinary Shares is current, except through “cashless exercise” as provided for
in the Warrant Agreement.

 

The Warrant Agreement provides
that upon the occurrence of certain events the number of Ordinary Shares issuable upon exercise of the Warrants set forth on the face
hereof may, subject to certain conditions, be adjusted. If, upon exercise of a Warrant, the holder thereof would be entitled to receive
a fractional interest in an Ordinary Share, the Company shall, upon exercise, round down to the nearest whole number of Ordinary Shares
to be issued to the holder of the Warrant.

 

Warrant Certificates, when
surrendered at the principal corporate trust office of the Warrant Agent by the Registered Holder thereof in person or by legal representative
or attorney duly authorized in writing, may be exchanged, in the manner and subject to the limitations provided in the Warrant Agreement,
but without payment of any service charge, for another Warrant Certificate or Warrant Certificates of like tenor evidencing in the aggregate
a like number of Warrants.

 

    

     

    

 

Upon due presentation for
registration of transfer of this Warrant Certificate at the office of the Warrant Agent, a new Warrant Certificate or Warrant Certificates
of like tenor and evidencing in the aggregate a like number of Warrants shall be issued to the transferee(s) in exchange for this
Warrant Certificate, subject to the limitations provided in the Warrant Agreement, without charge except for any tax or other governmental
charge imposed in connection therewith.

 

The Company and the Warrant
Agent may deem and treat the Registered Holder(s) hereof as the absolute owner(s) of this Warrant Certificate (notwithstanding
any notation of ownership or other writing hereon made by anyone), for the purpose of any exercise hereof, of any distribution to the
holder(s) hereof, and for all other purposes, and neither the Company nor the Warrant Agent shall be affected by any notice to the
contrary. Neither the Warrants nor this Warrant Certificate entitles any holder hereof to any rights of a shareholder of the Company.

 

    

     

    

 

Election to Purchase

(To Be Executed Upon Exercise of Warrant)

 

The
undersigned hereby irrevocably elects to exercise the right, represented by this Warrant Certificate, to receive [·]
Ordinary Shares and herewith tenders payment for such Ordinary Shares to the order of Gogoro Inc. (the “Company”)
in the amount of $[●] in accordance with the terms hereof. The undersigned requests that a certificate for such Ordinary Shares be registered
in the name of [·], whose address is [·]
and that such Ordinary Shares be delivered to [·], whose address is [·].
If said [·] number of Ordinary Shares is less than all of the Ordinary Shares purchasable
hereunder, the undersigned requests that a new Warrant Certificate representing the remaining balance of such Ordinary Shares be registered
in the name of [·], whose address is [·]
and that such Warrant Certificate be delivered to [·], whose address is [·].

 

In the event that the Warrant
has been called for redemption by the Company pursuant to Section 6.2 of the Warrant Agreement and a holder thereof elects
to exercise its Warrant pursuant to a Make-Whole Exercise, the number of Ordinary Shares that this Warrant is exercisable for shall be
determined in accordance with subsection 3.3.1(c) or Section 6.2 of the Warrant Agreement, as applicable.

 

In the event that the Warrant
is a Private Placement Warrant that is to be exercised on a “cashless” basis pursuant to subsection 3.3.1(c) of
the Warrant Agreement, the number of Ordinary Shares that this Warrant is exercisable for shall be determined in accordance with subsection
3.3.1(c) of the Warrant Agreement.

 

In the event that the Warrant
is to be exercised on a “cashless” basis pursuant to Section 7.4 of the Warrant Agreement, the number of Ordinary
Shares that this Warrant is exercisable for shall be determined in accordance with Section 7.4 of the Warrant Agreement.

 

In
the event that the Warrant may be exercised, to the extent allowed by the Warrant Agreement, through cashless exercise (i) the number
of Ordinary Shares that this Warrant is exercisable for would be determined in accordance with the relevant section of the Warrant Agreement
which allows for such cashless exercise and (ii) the holder hereof shall complete the following: The undersigned hereby irrevocably
elects to exercise the right, represented by this Warrant Certificate, through the cashless exercise provisions of the Warrant Agreement,
to receive Ordinary Shares. If said number of Ordinary Shares is less than all of the Ordinary Shares purchasable hereunder (after giving
effect to the cashless exercise), the undersigned requests that a new Warrant Certificate representing the remaining balance of such Ordinary
Shares be registered in the name of [·], whose address is [·]
and that such Warrant Certificate be delivered to [·], whose address is [·].

 

[Signature Page Follows]

 

    

     

    

 

Date [__], 20__

 

	 	 
	 	(Signature)
	 	 
	 	 
	 	 
	 	 
	 	(Address)
	 	 
	 	 
	 	(Tax Identification Number)

 

Signature Guaranteed:

 

	 	 

 

THE SIGNATURE(S) SHOULD BE GUARANTEED BY
AN ELIGIBLE GUARANTOR INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED
SIGNATURE GUARANTEE MEDALLION PROGRAM, PURSUANT TO S.E.C. RULE 17Ad-15 UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED).

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00333-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00333-of-00352.parquet"}]]